| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|
| levoplast | [no description available] | medium | 1 | 0 | C-nitro compound | |
| hippuric acid | [no description available] | medium | 1 | 0 | N-acylglycine | human blood serum metabolite;
uremic toxin |
| xanthine | [no description available] | medium | 1 | 0 | xanthine | Saccharomyces cerevisiae metabolite |
| atrolactic acid | [no description available] | medium | 1 | 0 | 2-hydroxy monocarboxylic acid | |
| etofylline | [no description available] | medium | 1 | 0 | oxopurine | |
| n-acetyltryptophan | [no description available] | medium | 1 | 0 | N-acetyl-amino acid;
tryptophan derivative | metabolite |
| ethacridine | [no description available] | medium | 1 | 0 | acridines | |
| altretamine | [no description available] | medium | 1 | 0 | triamino-1,3,5-triazine | |
| 2,5-di-tert-butylhydroquinone | [no description available] | medium | 1 | 0 | hydroquinones | |
| cx546 | [no description available] | medium | 1 | 0 | | |
| diphenhydramine | [no description available] | medium | 1 | 0 | ether;
tertiary amino compound | anti-allergic agent;
antidyskinesia agent;
antiemetic;
antiparkinson drug;
antipruritic drug;
antitussive;
H1-receptor antagonist;
local anaesthetic;
muscarinic antagonist;
oneirogen;
sedative |
| diuron | [no description available] | medium | 1 | 0 | 3-(3,4-substituted-phenyl)-1,1-dimethylurea;
dichlorobenzene | environmental contaminant;
mitochondrial respiratory-chain inhibitor;
photosystem-II inhibitor;
urea herbicide;
xenobiotic |
| ibuprofen | [no description available] | medium | 1 | 0 | monocarboxylic acid | antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic |
| ipriflavone | [no description available] | medium | 1 | 0 | aromatic ether;
isoflavones | bone density conservation agent |
| mebendazole | [no description available] | medium | 1 | 0 | aromatic ketone;
benzimidazoles;
carbamate ester | antinematodal drug;
microtubule-destabilising agent;
tubulin modulator |
| nocodazole | [no description available] | medium | 1 | 0 | aromatic ketone;
benzimidazoles;
carbamate ester;
thiophenes | antimitotic;
antineoplastic agent;
microtubule-destabilising agent;
tubulin modulator |
| piribedil | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
| procainamide | [no description available] | medium | 1 | 0 | benzamides | anti-arrhythmia drug;
platelet aggregation inhibitor;
sodium channel blocker |
| prometone | [no description available] | medium | 1 | 0 | diamino-1,3,5-triazine;
methoxy-1,3,5-triazine | environmental contaminant;
herbicide;
xenobiotic |
| propanil | [no description available] | medium | 1 | 0 | anilide;
dichlorobenzene | herbicide |
| sulfadimethoxine | [no description available] | medium | 1 | 0 | aromatic ether;
pyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide | antiinfective agent;
antimicrobial agent;
drug allergen;
environmental contaminant;
xenobiotic |
| sulfamethazine | [no description available] | medium | 1 | 0 | pyrimidines;
sulfonamide antibiotic;
sulfonamide | antibacterial drug;
antiinfective agent;
antimicrobial agent;
carcinogenic agent;
drug allergen;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
ligand;
xenobiotic |
| sulfathiazole | [no description available] | medium | 1 | 0 | 1,3-thiazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide | antiinfective agent;
drug allergen;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
xenobiotic |
| testosterone | [no description available] | medium | 1 | 0 | 3-hydroxy steroid | androgen |
| 2-hydroxybenzylbenzimidazole | [no description available] | medium | 1 | 0 | | |
| etimizol | [no description available] | medium | 1 | 0 | | |
| nifenalol | [no description available] | medium | 1 | 0 | C-nitro compound | |
| bis(4-hydroxyphenyl)sulfone | [no description available] | medium | 1 | 0 | bisphenol;
sulfone | endocrine disruptor;
metabolite |
| 8-hydroxyquinoline-5-sulfonic acid | [no description available] | medium | 1 | 0 | | |
| salicylanilide | [no description available] | medium | 1 | 0 | benzanilide fungicide;
salicylamides;
salicylanilides | |
| 2-phenylbutyric acid | [no description available] | medium | 1 | 0 | benzenes;
monocarboxylic acid | human xenobiotic metabolite |
| 4,4'-dimethoxybenzophenone | [no description available] | medium | 1 | 0 | | |
| 6-phenyl-1,3,5-triazine-2,4-diamine | [no description available] | medium | 1 | 0 | | |
| quinaldic acid | [no description available] | medium | 1 | 0 | quinolinemonocarboxylic acid | human metabolite;
Saccharomyces cerevisiae metabolite |
| N-(2-methoxyphenyl)acetamide | [no description available] | medium | 1 | 0 | acetamides;
methoxybenzenes | |
| fast red b | [no description available] | medium | 1 | 0 | | |
| methylenebis(chloroaniline) | [no description available] | medium | 1 | 0 | chloroaniline | metabolite |
| di-(4-aminophenyl)ether | [no description available] | medium | 1 | 0 | aromatic ether | |
| diphenylguanidine | [no description available] | medium | 1 | 0 | guanidines | allergen |
| 4-Anilino-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | anilide | |
| mephobarbital | [no description available] | medium | 1 | 0 | barbiturates | anticonvulsant |
| etryptamine | [no description available] | medium | 1 | 0 | indoles | |
| sulfacetamide | [no description available] | medium | 1 | 0 | | |
| cinchophen | [no description available] | medium | 1 | 0 | quinolines | |
| 2-aminobenzothiazole | [no description available] | medium | 1 | 0 | benzothiazoles | |
| carzenide | [no description available] | medium | 1 | 0 | sulfonamide | |
| nitrilotriacetic acid | [no description available] | medium | 1 | 0 | NTA;
tricarboxylic acid | carcinogenic agent;
nephrotoxic agent |
| n-(2-cyanoethyl)-2-phenylethylamine | [no description available] | medium | 1 | 0 | | |
| cyclooctane | [no description available] | medium | 1 | 0 | | |
| triphenyltetrazolium chloride | [no description available] | medium | 1 | 0 | organic chloride salt | dye;
indicator |
| 2,7-diacetylaminofluorene | [no description available] | medium | 1 | 0 | | |
| 3,4-pyridinedicarboxylic acid | [no description available] | medium | 1 | 0 | pyridinedicarboxylic acid | |
| 4-(benzoylamino)-2-hydroxybenzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
| tropic acid | [no description available] | medium | 1 | 0 | 3-hydroxy monocarboxylic acid | human xenobiotic metabolite |
| 8-hydroxy-7-iodo-5-quinolinesulfonic acid | [no description available] | medium | 1 | 0 | hydroxyquinoline | |
| 1-acetylisatin | [no description available] | medium | 1 | 0 | indoledione | |
| 4-cumylphenol | [no description available] | medium | 1 | 0 | diarylmethane | |
| 5-methylisatin | [no description available] | medium | 1 | 0 | | |
| 2-hydrazinobenzothiazole | [no description available] | medium | 1 | 0 | | |
| 1,2,3-trimethoxybenzene | [no description available] | medium | 1 | 0 | methoxybenzenes | plant metabolite |
| 2-amino-5-chlorobenzophenone | [no description available] | medium | 1 | 0 | | |
| diphenamid | [no description available] | medium | 1 | 0 | diarylmethane | |
| 4-(4-nitrobenzyl)pyridine | [no description available] | medium | 1 | 0 | | |
| 5-methyl-3-phenylisoxazole-4-carboxylic acid | [no description available] | medium | 1 | 0 | | |
| 2-acetylbenzofuran | [no description available] | medium | 1 | 0 | | |
| pyrazon | [no description available] | medium | 1 | 0 | benzenes;
organochlorine compound;
primary amino compound;
pyridazinone | environmental contaminant;
herbicide;
xenobiotic |
| 2-amino-5-nitrobenzophenone | [no description available] | medium | 1 | 0 | | |
| (4-tert-Butyl-phenoxy)-acetic acid | [no description available] | medium | 1 | 0 | monocarboxylic acid | |
| lenacil | [no description available] | medium | 1 | 0 | cyclopentapyrimidine | agrochemical;
environmental contaminant;
herbicide;
xenobiotic |
| chlordesmethyldiazepam | [no description available] | medium | 1 | 0 | benzodiazepine | |
| 2-amino-2',5-dichlorobenzophenone | [no description available] | medium | 1 | 0 | | |
| 2-(2'-hydroxyphenyl)benzimidazole | [no description available] | medium | 1 | 0 | | |
| 4-phthalimidobutyric acid | [no description available] | medium | 1 | 0 | | |
| azabutyrone | [no description available] | medium | 1 | 0 | | |
| 2-(2-hydroxyphenyl)benzothiazole | [no description available] | medium | 1 | 0 | benzothiazoles;
phenols | geroprotector |
| 4,5-dichlorocatechol | [no description available] | medium | 1 | 0 | | |
| n-butylbenzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | neurotoxin;
plant metabolite |
| 3-phenoxybenzoic acid | [no description available] | medium | 1 | 0 | phenoxybenzoic acid | human xenobiotic metabolite;
marine xenobiotic metabolite |
| 2-(2-hydroxyethylmercapto)benzothiazole | [no description available] | medium | 1 | 0 | | |
| carboxin | [no description available] | medium | 1 | 0 | anilide fungicide;
anilide;
enamide;
organosulfur heterocyclic compound;
oxacycle;
secondary carboxamide | antifungal agrochemical;
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor |
| meturin | [no description available] | medium | 1 | 0 | | |
| 2-bromo-N-phenylbenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-chlorohippuric acid | [no description available] | medium | 1 | 0 | | |
| 4-chlorophenoxyacetic acid | [no description available] | medium | 1 | 0 | chlorophenoxyacetic acid;
monochlorobenzenes | phenoxy herbicide |
| 2,5-dichloro-1,4-phenylenediamine | [no description available] | medium | 1 | 0 | | |
| metribuzin | [no description available] | medium | 1 | 0 | 1,2,4-triazines;
cyclic ketone;
organic sulfide | agrochemical;
environmental contaminant;
herbicide;
xenobiotic |
| 2,5-dimethyl-3-furancarboxanilide | [no description available] | medium | 1 | 0 | | |
| moricizine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anti-arrhythmia drug |
| 2-benzimidazolylguanidine | [no description available] | medium | 1 | 0 | aminoimidazole | |
| diflubenzuron | [no description available] | medium | 1 | 0 | benzoylurea insecticide;
monochlorobenzenes | insect sterilant |
| pentafluorobenzoyl-n-phenylethylamine | [no description available] | medium | 1 | 0 | | |
| thidiazuron | [no description available] | medium | 1 | 0 | ureas | |
| phenthiazamine | [no description available] | medium | 1 | 0 | | |
| 5,5-diphenylbarbituric acid | [no description available] | medium | 1 | 0 | | |
| 3-acetamidobenzoic acid | [no description available] | medium | 1 | 0 | | |
| dazoxiben hydrochloride | [no description available] | medium | 1 | 0 | | |
| succinylsulfanilamide | [no description available] | medium | 1 | 0 | | |
| benzylaminopurine | [no description available] | medium | 1 | 0 | 6-aminopurines | cytokinin;
plant metabolite |
| ciprofloxacin hydrochloride anhydrous | [no description available] | medium | 1 | 0 | hydrochloride | antibacterial drug;
antiinfective agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
topoisomerase IV inhibitor |
| src-820 r | [no description available] | medium | 1 | 0 | | |
| n(4)-acetylsulfadiazine | [no description available] | medium | 1 | 0 | acetamides;
pyrimidines;
sulfonamide | marine xenobiotic metabolite |
| 4-nitro-alpha-acetylamino-beta-hydroxypropiophenone | [no description available] | medium | 1 | 0 | | |
| formetamide | [no description available] | medium | 1 | 0 | | |
| isbufylline | [no description available] | medium | 1 | 0 | | |
| phenylacetylglycine | [no description available] | medium | 1 | 0 | monocarboxylic acid amide;
monocarboxylic acid;
N-acylglycine | human metabolite;
mouse metabolite |
| N-benzoylanthranilic acid | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
| butinoline | [no description available] | medium | 1 | 0 | diarylmethane | |
| n-(2-carboxyphenyl)glycine | [no description available] | medium | 1 | 0 | | |
| n,n-dimethyl-4-anisidine | [no description available] | medium | 1 | 0 | | |
| n-benzoylpiperidine | [no description available] | medium | 1 | 0 | benzamides;
N-acylpiperidine | |
| 2-phenylcyclopropanecarboxylic acid | [no description available] | medium | 1 | 0 | | |
| n-demethylantipyrine | [no description available] | medium | 1 | 0 | pyrazoles;
ring assembly | |
| 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine | [no description available] | medium | 1 | 0 | 1,2,4-triazines | |
| 2-amino-5-bromopyridine | [no description available] | medium | 1 | 0 | | |
| n-benzoylalanine, (dl-ala)-isomer | [no description available] | medium | 1 | 0 | alanine derivative;
N-acyl-amino acid | metabolite |
| bicinchoninic acid | [no description available] | medium | 1 | 0 | | |
| betamipron | [no description available] | medium | 1 | 0 | organonitrogen compound;
organooxygen compound | |
| benzoylpropionic acid | [no description available] | medium | 1 | 0 | 4-oxo monocarboxylic acid | hapten |
| Evoxine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound;
organonitrogen heterocyclic compound;
oxacycle | |
| 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid | [no description available] | medium | 1 | 0 | harmala alkaloid | |
| N-Benzylphthalimide | [no description available] | medium | 1 | 0 | isoindoles | |
| pyromellitic diimide | [no description available] | medium | 1 | 0 | | |
| 4'-bromosalicylanilide | [no description available] | medium | 1 | 0 | | |
| 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane | [no description available] | medium | 1 | 0 | bisphenol | |
| terephthalamide | [no description available] | medium | 1 | 0 | benzenedicarboxamide | |
| 3(2h)-pyridazinone, 4-chloro-5-(dimethylamino)-2-phenyl- | [no description available] | medium | 1 | 0 | | |
| 2-nitrophenylacetic acid | [no description available] | medium | 1 | 0 | C-nitro compound;
phenylacetic acids | |
| onychine | [no description available] | medium | 1 | 0 | | |
| 4'-methoxyflavone | [no description available] | medium | 1 | 0 | ether;
flavonoids | |
| 1,3-diphenyl-2-aminopropane | [no description available] | medium | 1 | 0 | | |
| 2,2-diphenylpropionic acid | [no description available] | medium | 1 | 0 | | |
| 3,4-dimethoxyphenylacetamide | [no description available] | medium | 1 | 0 | | |
| 2-amino-5-bromobenzoic acid | [no description available] | medium | 1 | 0 | | |
| 2-(1H-benzimidazol-2-yl)aniline | [no description available] | medium | 1 | 0 | benzimidazoles;
primary arylamine;
substituted aniline | geroprotector |
| N-Acetylhomoveratrylamine | [no description available] | medium | 1 | 0 | acetamides | |
| 2-chlorobenzenesulfonamide | [no description available] | medium | 1 | 0 | | |
| 4-nitrophenyl dimethylcarbamate | [no description available] | medium | 1 | 0 | | |
| 5-methoxyindole-3-carbaldehyde | [no description available] | medium | 1 | 0 | indoles | |
| 2-oxo-1,2-dihydroquinoline-4-carboxylic acid | [no description available] | medium | 1 | 0 | quinolinemonocarboxylic acid | |
| 6-methoxy-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one | [no description available] | medium | 1 | 0 | beta-carbolines | |
| pd 147953 | [no description available] | medium | 1 | 0 | | |
| fenozan | [no description available] | medium | 1 | 0 | | |
| 5-phenylbarbituric acid | [no description available] | medium | 1 | 0 | | |
| diethylpropion hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | appetite depressant |
| 1-(4'-nitrophenyl)-2-aminopropane-1,3-diol | [no description available] | medium | 1 | 0 | | |
| beta-hydroxyphenylalanine | [no description available] | medium | 1 | 0 | | |
| 3-(n-salicyloyl)amino-1,2,4-triazole | [no description available] | medium | 1 | 0 | | |
| 7-chloro-4-aminoquinoline | [no description available] | medium | 1 | 0 | aminoquinoline | |
| acridine-9-carboxylic acid | [no description available] | medium | 1 | 0 | | |
| 1-phenazinecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic carboxylic acid;
monocarboxylic acid;
phenazines | antifungal agent;
antimicrobial agent;
bacterial metabolite |
| 4,5-diphenyl-1,5-dihydroimidazol-2-one | [no description available] | medium | 1 | 0 | stilbenoid | |
| 2-hydroxy-1,2-bis(methoxyphenyl)ethanone | [no description available] | medium | 1 | 0 | | |
| 4-methyl-N-(phenylmethyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-n-butylaminobenzoic acid | [no description available] | medium | 1 | 0 | aromatic amino acid | |
| fluoren-9-ol | [no description available] | medium | 1 | 0 | | |
| 1-(2-carboxyethyl)uracil | [no description available] | medium | 1 | 0 | | |
| 1-benzylindole | [no description available] | medium | 1 | 0 | | |
| 2,3-bis(2-pyridinyl)quinoxaline | [no description available] | medium | 1 | 0 | quinoxaline derivative | |
| 3,3',5,5'-tetrachlorobiphenyl-4,4'-diol | [no description available] | medium | 1 | 0 | dichlorobenzene;
hydroxybiphenyls | |
| 5-nitro-2-(1-piperidinyl)pyridine | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 2-amino-5,7-dimethyl-1,8-naphthyridine | [no description available] | medium | 1 | 0 | | |
| 5-benzyloxytryptophan | [no description available] | medium | 1 | 0 | | |
| 2,5-diethoxy-4-morpholinoaniline | [no description available] | medium | 1 | 0 | | |
| 3-hydroxy-3-phenacyloxindole | [no description available] | medium | 1 | 0 | | |
| carbobenzoxyphenylalanine, (dl-phe)-isomer | [no description available] | medium | 1 | 0 | | |
| gamma-fagarine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound;
organonitrogen heterocyclic compound;
oxacycle | |
| 3-carboxymethyl-6-benzyl-2,5-diketopiperazine | [no description available] | medium | 1 | 0 | organonitrogen compound;
organooxygen compound | |
| 4-fluorobenzenesulfonamide | [no description available] | medium | 1 | 0 | | |
| emoxypine succinate | [no description available] | medium | 1 | 0 | | |
| n-carbamyltryptophan | [no description available] | medium | 1 | 0 | | |
| 2,4,6-trimethoxyacetophenone | [no description available] | medium | 1 | 0 | | |
| 1-(2-hydroxyethyl)-3,5-diphenyl-1h-pyrazole | [no description available] | medium | 1 | 0 | | |
| 4-methyoxybenzoyl-n-glycine | [no description available] | medium | 1 | 0 | N-acylglycine | |
| 5-ethoxy-2-ethylmercaptobenzimidazole | [no description available] | medium | 1 | 0 | | |
| 5(6)-1(2h)-phthalazinonyl-4(1h)-benzimidazole-2-carbamate methyl ester | [no description available] | medium | 1 | 0 | | |
| n-phenyliminodiacetic acid | [no description available] | medium | 1 | 0 | | |
| teomorfolin | [no description available] | medium | 1 | 0 | | |
| 1-(1,3-benzodioxol-5-yl)-3-(1-piperidinyl)-1-propanone | [no description available] | medium | 1 | 0 | benzodioxoles | |
| n-(aminocarbonyl)-2-chlorobenzenesulfonamide | [no description available] | medium | 1 | 0 | | |
| 3-hydroxy-2-quinoxalinepropionic acid | [no description available] | medium | 1 | 0 | | |
| 8-(methylsulfonylamino)quinoline | [no description available] | medium | 2 | 0 | | |
| n(4)-acetylsulfamonomethoxine | [no description available] | medium | 1 | 0 | | |
| 8-(4-benzenesulfonylamino)quinoline | [no description available] | medium | 4 | 0 | | |
| methindione | [no description available] | medium | 1 | 0 | | |
| 3,4-dihydroxybenzophenone | [no description available] | medium | 1 | 0 | | |
| gamma-propanol | [no description available] | medium | 1 | 0 | | |
| 2-[(3-oxo-1-cyclohexenyl)amino]benzonitrile | [no description available] | medium | 1 | 0 | benzenes;
nitrile | |
| isonicotinylamide gaba | [no description available] | medium | 1 | 0 | | |
| 5-fluorotryptamine monohydrochloride | [no description available] | medium | 1 | 0 | | |
| 4-iodo-n-(2-(4-morpholinyl)ethyl)benzamide | [no description available] | medium | 1 | 0 | | |
| 3-(hydroxyacetyl)indole | [no description available] | medium | 1 | 0 | indoles | |
| n-(4-aminophenylsulfonyl)morpholine | [no description available] | medium | 1 | 0 | | |
| 1H-indol-3-yl-(4-methoxyphenyl)methanone | [no description available] | medium | 1 | 0 | N-acylindole | |
| 2-amino-5-phenyl-1,3,4-thiadiazole | [no description available] | medium | 1 | 0 | | |
| N-(1-phenylethyl)acetamide | [no description available] | medium | 1 | 0 | acetamides;
secondary carboxamide | |
| alpha-(trichloromethyl)-4-pyridineethanol | [no description available] | medium | 1 | 0 | pyridines | |
| ml 204 | [no description available] | medium | 1 | 0 | | |
| eudesmin | [no description available] | medium | 1 | 0 | | |
| 2-amino-4-methyl-3-nitropyridine | [no description available] | medium | 1 | 0 | | |
| 4,4-bis(hydroxymethyl)-2-phenyl-2-oxazoline | [no description available] | medium | 1 | 0 | | |
| n-acetylhistidine | [no description available] | medium | 1 | 0 | histidine derivative;
N-acetyl-amino acid | |
| 1-(1-oxo-2-phenylethyl)-4-piperidinecarboxylic acid | [no description available] | medium | 1 | 0 | acetamides | |
| 1-(4-chlorophenyl)-3-(2-ethoxyphenyl)urea | [no description available] | medium | 1 | 0 | ureas | |
| 4-methoxyxanthone | [no description available] | medium | 1 | 0 | | |
| N-(4-nitrophenyl)-2-phenoxyacetamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 1-phenylindolin-2-one | [no description available] | medium | 1 | 0 | | |
| 1-(benzenesulfonyl)indole | [no description available] | medium | 1 | 0 | sulfonamide | |
| 2,4,4,6-Tetramethyl-1,4-dihydro-3,5-pyridinedicarbonitrile | [no description available] | medium | 1 | 0 | dihydropyridine | |
| pifithrin mu | [no description available] | medium | 1 | 0 | benzenes | |
| 2-benzyloxybenzaldehyde | [no description available] | medium | 1 | 0 | | |
| 2-guanidine-4-methylquinazoline | [no description available] | medium | 1 | 0 | | |
| N-phenylcarbamic acid 2-phenoxyethyl ester | [no description available] | medium | 1 | 0 | carbamate ester | |
| 3,4-dihydro-2H-benzo[4,5]imidazo[2,1-b][1,3]thiazin-3-ol | [no description available] | medium | 1 | 0 | benzimidazoles | |
| mequindox | [no description available] | medium | 1 | 0 | | |
| N-[2-(dimethylamino)ethyl]-2,2-diphenylacetamide | [no description available] | medium | 1 | 0 | diarylmethane | |
| Girgensonine | [no description available] | medium | 1 | 0 | nitrile | |
| Dubinidine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound;
organonitrogen heterocyclic compound;
oxacycle | |
| N-[4-(methanesulfonamido)phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-(2-oxazolo[4,5-b]pyridinyl)aniline | [no description available] | medium | 1 | 0 | 1,3-oxazoles | |
| 2-[(4-nitrophenyl)methylthio]-1,3-benzoxazole | [no description available] | medium | 1 | 0 | benzoxazole | |
| 3-oxido-4,5-dihydro-[1,2,5]oxadiazolo[3,4-f]cinnolin-3-ium | [no description available] | medium | 1 | 0 | pyridazines | |
| 3-(2,4-difluoroanilino)-5,5-dimethyl-1-cyclohex-2-enone | [no description available] | medium | 1 | 0 | substituted aniline | |
| 1-phenyl-4-pyrazolol | [no description available] | medium | 1 | 0 | pyrazoles;
ring assembly | |
| 3-(3,5-dimethyl-1-pyrazolyl)-1,2-benzothiazole 1,1-dioxide | [no description available] | medium | 1 | 0 | benzothiazoles | |
| 3-benzamido-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | benzofurans | |
| N-[2-(4-methoxyphenyl)ethyl]acetamide | [no description available] | medium | 1 | 0 | acetamides | |
| N-[2-(3-methylphenoxy)ethyl]-1H-1,2,4-triazole-5-carboxamide | [no description available] | medium | 1 | 0 | aromatic ether | |
| 2-(1H-indol-3-ylthio)acetic acid | [no description available] | medium | 1 | 0 | indoles | |
| 3-bromo-N-[2-(4-nitroanilino)ethyl]benzamide | [no description available] | medium | 1 | 0 | carbonyl compound;
organohalogen compound | |
| 3-Methylbenzofuran-2-carboxylic acid | [no description available] | medium | 1 | 0 | benzofurans | |
| 5-(3,4-dimethoxyphenyl)-2H-tetrazole | [no description available] | medium | 1 | 0 | tetrazoles | |
| 1-(4-fluorophenyl)sulfonyl-4-(2-methoxyphenyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| 4-[[bis(2-hydroxyethyl)amino]methyl]-2,6-ditert-butylphenol | [no description available] | medium | 1 | 0 | alkylbenzene | |
| 2-phenylindole-3-carbaldehyde | [no description available] | medium | 1 | 0 | | |
| 4-(2-pyridinylthio)benzofuro[3,2-d]pyrimidine | [no description available] | medium | 1 | 0 | aryl sulfide | |
| 5-(4-nitrophenyl)-4-phenyl-2-thiazolamine | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 3-[6-(4-aminophenyl)-2-phenyl-4-pyrimidinyl]aniline | [no description available] | medium | 1 | 0 | pyrimidines | |
| 7-methoxyisoflavone | [no description available] | medium | 1 | 0 | 7-methoxyisoflavones | |
| LSM-32392 | [no description available] | medium | 1 | 0 | monoterpenoid | |
| N-[2-(1-cyclohexenyl)ethyl]-4-(4-morpholinylmethyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 1-(1-benzimidazolyl)-3-(1-cyclohex-3-enylmethoxy)-2-propanol | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-[2-(2-furanylmethylthio)ethyl]-4-methoxybenzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-acetamido-5-chloro-2-benzofurancarboxylic acid | [no description available] | medium | 1 | 0 | benzofurans | |
| [4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-(2,6-dimethoxyphenyl)methanone | [no description available] | medium | 1 | 0 | dimethoxybenzene | |
| 4-[4-methyl-6-(4-methyl-1-piperazinyl)-2-pyrimidinyl]morpholine | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
| haplamine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound;
organonitrogen heterocyclic compound;
oxacycle | |
| 5-(3,4-dimethoxyphenyl)-1H-1,2,4-triazol-3-amine | [no description available] | medium | 1 | 0 | triazoles | |
| 2-ethoxy-N-[4-(4-morpholinylsulfonyl)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 2-[(5-methyl-1H-1,2,4-triazol-3-yl)thio]-1-phenylethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 1-ethyl-6-methoxy-4-oxo-3-quinolinecarboxylic acid | [no description available] | medium | 1 | 0 | quinolines | |
| 2-(pyridin-4-yl)-4-(pyrrolidin-1-yl)quinazoline | [no description available] | medium | 1 | 0 | pyridines;
pyrrolidines;
quinazolines | |
| scp 1 | [no description available] | medium | 1 | 0 | | |
| N-(3-acetamidophenyl)-4-methoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(3-acetamidophenyl)-3-chlorobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-methoxy-N-(5-methyl-3-isoxazolyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(2-fluorophenyl)-4-phenylmethoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-[4-(diethylamino)phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide;
furans | |
| N-(2-furanylmethyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | benzofurans | |
| 5-(2-phenylethyl)-1,3,4-thiadiazol-2-amine | [no description available] | medium | 1 | 0 | aromatic amine;
thiadiazoles | |
| te 5 | [no description available] | medium | 1 | 0 | | |
| 2-[[anilino(oxo)methyl]amino]-4,5-dimethyl-3-thiophenecarboxamide | [no description available] | medium | 1 | 0 | ureas | |
| N-(4,6-dimethyl-2-pyrimidinyl)-1,3-benzothiazol-2-amine | [no description available] | medium | 1 | 0 | benzothiazoles | |
| 6-methylflavone | [no description available] | medium | 1 | 0 | | |
| 2-methoxy-N-(2-pyridinyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 2-chloro-N-(2-phenylethyl)benzamide | [no description available] | medium | 1 | 0 | carbonyl compound;
organohalogen compound | |
| N1-(4H-1,2,4-triazol-4-yl)-4-nitrobenzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
| N-[2-(1-cyclohexenyl)ethyl]-4-fluorobenzamide | [no description available] | medium | 1 | 0 | carbonyl compound;
organohalogen compound | |
| tioxazafen | [no description available] | medium | 1 | 0 | 1,2,4-oxadiazole;
thiophenes | agrochemical;
nematicide |
| N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| 1-(4-Methoxyphenyl)-2-nitroethylene | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| brd32048 | [no description available] | medium | 1 | 0 | methoxybenzenes;
substituted aniline | |
| 2-(4-chloro-3-methylphenoxy)-N-(1H-1,2,4-triazol-5-yl)acetamide | [no description available] | medium | 1 | 0 | aromatic ether | |
| 2-(3,4-dichlorophenyl)imidazo[1,2-a]pyrimidine | [no description available] | medium | 1 | 0 | imidazoles | |
| 5-(2-phenyl-4-triazolyl)-2H-tetrazole | [no description available] | medium | 1 | 0 | triazoles | |
| N-cyclohexyl-2,3-dihydroindole-1-carboxamide | [no description available] | medium | 1 | 0 | indolyl carboxylic acid | |
| 4-(benzylsulfanyl)thieno[2,3-d]pyrimidine | [no description available] | medium | 1 | 0 | aryl sulfide;
benzenes;
thienopyrimidine | |
| 2-methyl-5-(5-methyl-2-furanyl)-3-(1-pyrrolyl)-4-thieno[2,3-d]pyrimidinone | [no description available] | medium | 1 | 0 | organic heterobicyclic compound;
organonitrogen heterocyclic compound;
organosulfur heterocyclic compound | |
| 1-[2-(dimethylamino)ethyl]-5-methoxy-N-methyl-2-indolecarboxamide | [no description available] | medium | 1 | 0 | indolecarboxamide | |
| N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-methoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-(1H-benzimidazol-2-yl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
| 1-(4-Chlorophenyl)-2-[(1-methyl-1H-imidazol-2-yl)thio]ethan-1-one | [no description available] | medium | 1 | 0 | aromatic ketone | |
| N-(2,5-dimethylphenyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide;
furans | |
| N-(4-methoxyphenyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide;
furans | |
| 2-(9h-xanthen-9-yl)-malonic acid | [no description available] | medium | 1 | 0 | xanthenes | |
| 1-(1,3-benzothiazol-2-yl)-3-phenylurea | [no description available] | medium | 1 | 0 | ureas | |
| 1-hydroxy-2-phenyl-1,5,6,7-tetrahydro-4H-benzimidazol-4-one | [no description available] | medium | 1 | 0 | imidazoles | |
| N-(4-acetamidophenyl)-2-bromobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-bromo-N-phenacylbenzamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 1-(2,3-dihydroindol-1-yl)-2-(phenylthio)ethanone | [no description available] | medium | 1 | 0 | indoles | |
| N-[6-methyl-2-(4-methylphenyl)-5-benzotriazolyl]-3-pyridinecarboxamide | [no description available] | medium | 1 | 0 | triazoles | |
| N,N-dimethyl-N'-p-tolylsulfamide | [no description available] | medium | 1 | 0 | sulfamides | marine xenobiotic metabolite |
| 2-(1-piperidinylmethyl)phenol | [no description available] | medium | 1 | 0 | | |
| 2,6-bis(benzimidazol-2-yl)pyridine | [no description available] | medium | 1 | 0 | benzimidazoles | |
| 1-cyclohexyl-3-(2-phenylethyl)urea | [no description available] | medium | 1 | 0 | benzenes | |
| 1-(3,5-dichlorophenyl)-3-phenylurea | [no description available] | medium | 1 | 0 | ureas | |
| 1-(cyclohexylmethyl)-4-phenylpiperazine | [no description available] | medium | 1 | 0 | piperazines | |
| N-phenethyl-2-furamide | [no description available] | medium | 1 | 0 | aromatic amide;
heteroarene | |
| paromomycin sulfate | [no description available] | medium | 1 | 0 | | |
| N,N,2-trimethyl-1-phenyl-5-benzimidazolesulfonamide | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-(phenylmethyl)-4-(3-pyridinyl)-2-thiazolamine | [no description available] | medium | 1 | 0 | aralkylamine | |
| N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | monoterpenoid | |
| 2-amino-5-ethyl-4-(2-furanyl)-6-propyl-3-pyridinecarbonitrile | [no description available] | medium | 1 | 0 | nitrile;
pyridines | |
| 2-ethoxy-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| vu0099704 | [no description available] | medium | 1 | 0 | | |
| 3-(4-chlorophenyl)-2,5-dimethyl-1H-pyrazolo[1,5-a]pyrimidin-7-one | [no description available] | medium | 1 | 0 | pyrazoles;
ring assembly | |
| 1-(2-chloro-6-fluorophenyl)-[1,2,4]triazolo[4,3-a]quinoline | [no description available] | medium | 1 | 0 | triazoles | |
| 2-methyl-N-(1-methyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)propanamide | [no description available] | medium | 1 | 0 | pyrroloquinoline | |
| 2-methyl-5-[(2-methyl-4-quinolinyl)thio]-1,3,4-thiadiazole | [no description available] | medium | 1 | 0 | aryl sulfide | |
| 5-methyl-1-(4-nitrophenyl)-2-oxo-2,5-dihydro-1h-pyrido(3,2-b)indole-3-carbonitrile | [no description available] | medium | 1 | 0 | | |
| (3-hydroxy-5,6,7,8-tetrahydro-4H-cyclohepta[d]imidazol-2-yl)-phenylmethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 2-fluoro-N-phenacylbenzamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 4-(methoxymethyl)-6-methyl-2-(2-methylanilino)-3-pyridinecarbonitrile | [no description available] | medium | 1 | 0 | nitrile;
pyridines | |
| 1-azepanyl-[2-methoxy-4-(methylthio)phenyl]methanone | [no description available] | medium | 1 | 0 | carbonyl compound;
thiol | |
| GS4012 free base | [no description available] | medium | 1 | 0 | aryl sulfide;
monomethoxybenzene;
pyridines | VEGF activator |
| N-[1-(4-methylphenyl)-5-benzimidazolyl]acetamide | [no description available] | medium | 1 | 0 | benzimidazoles | |
| 2-(4-methylanilino)-1-(4-nitrophenyl)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| N-(2,6-dimethylphenyl)-N(2)-(3,5-dimethylphenyl)glycinamide | [no description available] | medium | 1 | 0 | amino acid amide;
glycine derivative | |
| 2-[4-[(3-fluorophenyl)methyl]-1-piperazinyl]pyrimidine | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
| 1-[(3,4-dimethoxyphenyl)methyl]-4-(2,3-dimethylphenyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| 4-Piperidinobenzoic acid | [no description available] | medium | 1 | 0 | piperidines | |
| 1-(2-methoxyphenyl)-4-(3-thiophenylmethyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| N-(1-methyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)-2-(1-pyrrolidinyl)acetamide | [no description available] | medium | 1 | 0 | pyrroloquinoline | |
| 4-[(1H-benzimidazol-2-ylthio)methyl]-2-thiazolamine | [no description available] | medium | 1 | 0 | benzimidazoles | |
| 4-[(4-phenyl-2-thiazolyl)amino]benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| N-[7-(1-oxopropyl)-2,3-dihydro-1,4-benzodioxin-6-yl]benzamide | [no description available] | medium | 1 | 0 | benzodioxine | |
| N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide;
furans | |
| n-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine | [no description available] | medium | 1 | 0 | | |
| 8-(3,5-dimethyl-1-pyrazolyl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
| 2'-nitroflavone | [no description available] | medium | 1 | 0 | | |
| N-(4-methoxyphenyl)-3,4-dihydroquinolin-2-amine | [no description available] | medium | 1 | 0 | aminoquinoline | |
| 1-(3-nitrophenyl)-3-phenyl-2-propyn-1-one | [no description available] | medium | 1 | 0 | aromatic compound | |
| vrt 532 | [no description available] | medium | 1 | 0 | | |
| 4-[[4-(2,5-dimethylphenyl)-1-piperazinyl]methyl]-2-methoxyphenol | [no description available] | medium | 1 | 0 | piperazines | |
| 1-piperonylpiperidine | [no description available] | medium | 1 | 0 | | |
| 2-[(3-fluorophenyl)methyl-(phenylmethyl)amino]ethanol | [no description available] | medium | 1 | 0 | aromatic amine | |
| 2-methoxy-4-[[2-(methylthio)anilino]methyl]phenol | [no description available] | medium | 1 | 0 | aromatic amine | |
| 6-ethyl-5-methyl-2-thiophen-2-yl-1H-pyrazolo[1,5-a]pyrimidin-7-one | [no description available] | medium | 1 | 0 | pyrazolopyrimidine | |
| N-[4-(2-methyl-4-thiazolyl)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(6-phenyl-5-imidazo[2,1-b]thiazolyl)benzamide | [no description available] | medium | 1 | 0 | imidazoles | |
| 2-(phenylmethylthio)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole | [no description available] | medium | 1 | 0 | aryl sulfide | |
| 5-methyl-N-(4,5,6-trimethyl-2-pyrimidinyl)-1,3-benzoxazol-2-amine | [no description available] | medium | 1 | 0 | benzoxazole | |
| 1-(4-methoxyphenyl)-3-(6-methyl-2-pyridinyl)urea | [no description available] | medium | 1 | 0 | ureas | |
| 2-{[hydroxy(2-methoxyphenyl)methylidene]amino}acetic acid | [no description available] | medium | 1 | 0 | N-acylglycine | |
| (4-methoxyphenyl)-(3-methyl-2-propyl-4-imidazolyl)methanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| N-(3-acetamidophenyl)-2-chlorobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N4,N4-dimethyl-N1-(4-nitro-1,1-dioxo-2,5-dihydrothiophen-3-yl)benzene-1,4-diamine | [no description available] | medium | 1 | 0 | dialkylarylamine;
tertiary amino compound | |
| 2-bromo-N-(3-methoxyphenyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 2-methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol | [no description available] | medium | 1 | 0 | aromatic ether;
C-nitro compound | |
| 3-[[(2,5-dimethyl-3-furanyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | aromatic amide;
furans | |
| 1-(4-ethoxyphenyl)-3-(6-quinoxalinyl)urea | [no description available] | medium | 1 | 0 | quinoxaline derivative | |
| 2-(dimethylsulfamoylamino)-9H-fluorene | [no description available] | medium | 1 | 0 | fluorenes | |
| 4-chloro-1-ethyl-3-nitro-2-quinolinone | [no description available] | medium | 1 | 0 | nitro compound;
quinolines | |
| 4-chloro-3-nitro-1-(phenylmethyl)-2-quinolinone | [no description available] | medium | 1 | 0 | quinolines | |
| 2,5-dimethyl-1-(phenylmethyl)pyrrole-3,4-dicarboxaldehyde | [no description available] | medium | 1 | 0 | arenecarbaldehyde | |
| 2-(2-chloro-6-fluorophenyl)-1-(2,4-dihydroxyphenyl)ethanone | [no description available] | medium | 1 | 0 | stilbenoid | |
| 4-methyl-N-(3-nitrophenyl)-5-phenyl-3-thiophenecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-2,2,2-trichloroacetamide | [no description available] | medium | 1 | 0 | triazoles | |
| N-(2-fluoro-5-methylphenyl)-3-phenylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
| N-[(4-fluorophenyl)methyl]-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | organofluorine compound | |
| 4-tert-butyl-N-(1,4-dioxo-2,3-dihydrophthalazin-5-yl)benzamide | [no description available] | medium | 1 | 0 | phthalazines | |
| N-[2-(2-methylpropyl)-1,3-dioxo-5-isoindolyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | phthalimides | |
| 6-(1,4,5,7-tetramethyl-6-pyrrolo[3,4-d]pyridazinyl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
| 2-(3,4-dimethoxyphenyl)-1-(2,4,6-trihydroxyphenyl)ethanone | [no description available] | medium | 1 | 0 | stilbenoid | |
| 5-(3-chloro-4-methylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole;
ring assembly | |
| 5-(phenylmethyl)-3-(2-pyridinyl)-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | pyridines | |
| 2-methyl-5-(1-pyrrolidinyl)isoindole-1,3-dione | [no description available] | medium | 1 | 0 | phthalimides | |
| (2'-(4-aminophenyl)-(2,5'-bi-1h-benzimidazol)-5-amine) | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-(4-bromo-2-fluorophenyl)-2-methyl-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide;
furans | |
| 6,7,8,9-tetrahydro-5H-carbazole-3-carbohydrazide | [no description available] | medium | 1 | 0 | carbazoles | |
| N-(3-carbamoyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-2-pyrazinecarboxamide | [no description available] | medium | 1 | 0 | primary carboxamide;
pyrazines;
secondary carboxamide | |
| N-(1,3-benzodioxol-5-yl)-5-methyl-2-furancarboxamide | [no description available] | medium | 1 | 0 | benzodioxoles | |
| 1-cyclohexyl-3-(2,3-dihydro-1,4-benzodioxin-6-yl)urea | [no description available] | medium | 1 | 0 | benzodioxine | |
| 8-[(2-methyl-5-nitro-1,2,4-triazol-3-yl)thio]quinoline | [no description available] | medium | 1 | 0 | aryl sulfide | |
| 1-[2-(2-chlorophenoxy)ethyl]benzimidazole | [no description available] | medium | 1 | 0 | benzimidazoles | |
| 4,5-dimethyl-2-[4-(3-nitrophenyl)-2-thiazolyl]-1H-pyrazol-3-one | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 2-(4-fluoro-N-methylsulfonylanilino)-N-(3-methylphenyl)acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 1-(4-fluorophenyl)-2-(2-pyridinylthio)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 3-methyl-6-(1-pyrrolidinyl)-[1,2,4]triazolo[4,3-b]pyridazine | [no description available] | medium | 1 | 0 | triazolopyridazine | |
| N-(3-acetylphenyl)-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
| oncrasin-1 | [no description available] | medium | 1 | 0 | arenecarbaldehyde;
indoles;
monochlorobenzenes | antineoplastic agent;
apoptosis inducer |
| N-[2-(4-fluorophenyl)ethyl]-4-nitrobenzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 5-(1-methyl-2-benzimidazolyl)-2-thiophenecarboxaldehyde | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-(4-anilinophenyl)-2-methylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
| N-(2-fluorophenyl)-3-phenylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
| 1-[(Phenylthio)acetyl]piperidine | [no description available] | medium | 1 | 0 | N-acylpiperidine | |
| N-(3-hydroxyphenyl)-5-methyl-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide;
furans | |
| 3-(4-methoxyphenyl)-5-(4-methylphenyl)-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole;
ring assembly | |
| 4-[(4-carboxy-2,6-dimethoxyphenoxy)methyl]-5-methyl-2-furancarboxylic acid | [no description available] | medium | 1 | 0 | trihydroxybenzoic acid | |
| 4-(4-morpholinylmethyl)-3-quinolinol | [no description available] | medium | 1 | 0 | quinolines | |
| 2-bromo-N-[3-(1-oxopropylamino)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 3-acetyl-2-methylbenzo[f]benzofuran-4,9-dione | [no description available] | medium | 1 | 0 | naphthofuran | |
| 5-(4-chlorophenyl)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide;
heteroarene | |
| 1-azepanyl-[4-[(phenylthio)methyl]phenyl]methanone | [no description available] | medium | 1 | 0 | benzamides | |
| 1-(5-ethyl-2,4-dihydroxyphenyl)-2-(2-fluorophenoxy)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
| N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(2-nitrophenyl)acetamide | [no description available] | medium | 1 | 0 | acetamides | |
| 3,4,5-triethoxy-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 1-propylsulfonyl-4-(2-pyridinyl)piperazine | [no description available] | medium | 1 | 0 | piperazines;
pyridines | |
| 2-(2-phenylethylthio)-3-pyridinecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic carboxylic acid;
pyridines | |
| 2-(2,3-dimethylphenoxy)-N-pyridin-4-ylacetamide | [no description available] | medium | 1 | 0 | aromatic ether | |
| 2-[[anilino(oxo)methyl]amino]-N-(phenylmethyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(5-acetyl-4-methyl-2-thiazolyl)-5-bromo-2-furancarboxamide | [no description available] | medium | 1 | 0 | thiazoles | |
| 1-cyclohexyl-3-(3-ethylphenyl)urea | [no description available] | medium | 1 | 0 | ureas | |
| n-phenylpiracetam | [no description available] | medium | 1 | 0 | | |
| 2-[(1-methyl-5-tetrazolyl)thio]-N-(2-phenylphenyl)acetamide | [no description available] | medium | 1 | 0 | biphenyls | |
| N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-nitrobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-N-(2,6-dimethylphenyl)benzamide | [no description available] | medium | 1 | 0 | isoquinolines | |
| 5-(4-bromophenyl)-N-(2-methoxyphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide;
furans | |
| 3-[[(3,5-dichloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
| 1,4-bis(thiophen-2-ylsulfonyl)piperazine | [no description available] | medium | 1 | 0 | N-sulfonylpiperazine;
thiophenes | |
| 2-bromo-N-[3-(1-oxobutylamino)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 1-(2-fluorophenyl)-4-[(6-nitro-1,3-benzodioxol-5-yl)methyl]piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| n-(1-benzyl-4-piperidinyl)-2,4-dichlorobenzamide | [no description available] | medium | 1 | 0 | | |
| 2-[[2-(5-methyl-2-thiophenyl)-2-oxoethyl]thio]-3-phenyl-4-quinazolinone | [no description available] | medium | 1 | 0 | quinazolines | |
| 1-(2,1,3-benzothiadiazol-5-yl)-3-[4-(4-morpholinyl)phenyl]urea | [no description available] | medium | 1 | 0 | morpholines | |
| ethyl 4-{N-[(4-chlorophenyl)sulfonyl]-N-methylglycyl}piperazine-1-carboxylate | [no description available] | medium | 1 | 0 | carbamate ester;
sulfonamide | |
| LSM-4563 | [no description available] | medium | 1 | 0 | aromatic ketone | |
| 1-(4-chloro-3-methoxyphenyl)sulfonyl-4-phenylpiperazine | [no description available] | medium | 1 | 0 | piperazines | |
| N-[4-[(3,4-dimethoxyphenyl)sulfamoyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 1-(2,5-dimethoxyphenyl)sulfonyl-4-(phenylmethyl)piperazine | [no description available] | medium | 1 | 0 | sulfonamide | |
| 2-(4-methoxyphenyl)-N-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-[4-(benzenesulfonyl)-1-piperazinyl]-2-methylquinoline | [no description available] | medium | 1 | 0 | piperazines;
pyridines | |
| 1-(6-methoxy-2,2,4-trimethyl-1-quinolinyl)-2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]thio]ethanone | [no description available] | medium | 1 | 0 | quinolines | |
| N2-phenyl-6-[[(1-phenyl-5-tetrazolyl)thio]methyl]-1,3,5-triazine-2,4-diamine | [no description available] | medium | 1 | 0 | tetrazoles | |
| 2-[(4,6-dimethyl-2-pyrimidinyl)thio]-N-(4,5-diphenyl-2-oxazolyl)acetamide | [no description available] | medium | 1 | 0 | 1,3-oxazoles | |
| 2-(4-bromophenyl)-1-[4-(2-pyridinyl)-1-piperazinyl]ethanone | [no description available] | medium | 1 | 0 | piperazines;
pyridines | |
| 2-amino[1,3]thiazolo[4,5-d]pyrimidine-5,7-diol | [no description available] | medium | 1 | 0 | thiazolopyrimidine | |
| 3-[[(2-cyclohexyl-1,3-dioxo-5-isoindolyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | aromatic amide | |
| 3-[[[3-(1-azepanylsulfonyl)-4-chlorophenyl]-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
| 2-(4-bromophenyl)-N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)acetamide | [no description available] | medium | 1 | 0 | acetamides | |
| 5-(1,3-benzodioxol-5-ylsulfamoyl)-2-methoxybenzoic acid | [no description available] | medium | 1 | 0 | methoxybenzoic acid | |
| N-cycloheptyl-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-(2-chlorophenyl)-5-methyl-N-[4-[2-(4-morpholinyl)-2-oxoethoxy]phenyl]-4-isoxazolecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| N-[3-[[(4-nitrophenyl)-oxomethyl]amino]phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | benzamides | |
| 3-methyl-1,5-dithiophen-2-ylpentane-1,5-dione | [no description available] | medium | 1 | 0 | aromatic ketone | |
| N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-(dimethylsulfamoyl)-N-(4-thiophen-2-yl-2-thiazolyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-chloro-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| N-(3,4-dimethoxyphenyl)-4-[(4-phenyl-1-piperazinyl)methyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| stk295900 | [no description available] | medium | 1 | 0 | | |
| 1-(3-chlorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]piperazine | [no description available] | medium | 1 | 0 | piperazines | |
| 2-[4-[[4-(4-methoxyphenyl)-1-phthalazinyl]amino]phenyl]acetamide | [no description available] | medium | 1 | 0 | pyridazines;
ring assembly | |
| 1-(2-fluorophenyl)-3-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]urea | [no description available] | medium | 1 | 0 | ureas | |
| N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| N-(1,3-benzodioxol-5-yl)-4-methyl-1-phthalazinamine | [no description available] | medium | 1 | 0 | phthalazines | |
| SMER 28 | [no description available] | medium | 1 | 0 | organobromine compound;
quinazolines;
secondary amino compound | autophagy inducer |
| N-[4-(4-morpholinyl)phenyl]carbamic acid butyl ester | [no description available] | medium | 1 | 0 | morpholines | |
| 4-(4-chlorophenoxy)-1-(4-morpholinyl)-1-butanone | [no description available] | medium | 1 | 0 | aromatic ether | |
| 4-(4-chlorophenoxy)-1-(1-piperidinyl)-1-butanone | [no description available] | medium | 1 | 0 | N-acylpiperidine | |
| N-(3-phenylpropyl)methanesulfonamide | [no description available] | medium | 1 | 0 | benzenes | |
| 4-acetamido-N-(2-methoxyethyl)benzamide | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
| 2-methyl-N-(2,3,4,5,6-pentafluorophenyl)-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide;
furans | |
| 3,4-dihydro-2H-quinolin-1-yl-(4-propoxyphenyl)methanone | [no description available] | medium | 1 | 0 | quinolines | |
| 5-bromo-N-(2-phenylphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide;
furans | |
| 2-[2-(4-chlorophenoxy)ethylthio]pyrimidine | [no description available] | medium | 1 | 0 | aromatic ether | |
| 3-(3-bromoanilino)-1-(5-methyl-2-furanyl)-1-propanone | [no description available] | medium | 1 | 0 | aralkylamine | |
| 4-[2-(4-bromo-2-chlorophenoxy)-1-oxoethyl]-1-piperazinecarboxylic acid ethyl ester | [no description available] | medium | 1 | 0 | piperazinecarboxylic acid | |
| 2-[2-[[3-(1,3-benzoxazol-2-yl)anilino]-oxomethyl]phenyl]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
| 1-[2-(2-chlorophenoxy)ethoxy]-2-methoxy-4-methylbenzene | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| N-[4-[(4-sulfamoylphenyl)sulfamoyl]phenyl]cyclopropanecarboxamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4-[2-[2-(4-bromo-2-chlorophenoxy)ethoxy]ethyl]morpholine | [no description available] | medium | 1 | 0 | aromatic ether | |
| N-[2-(2-phenylphenoxy)ethyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | biphenyls | |
| 5,6,7,8-tetrafluoro-2-(2,3,4,5,6-pentafluorophenyl)-4h-1-benzopyran-4-one | [no description available] | medium | 1 | 0 | | |
| 2-[bis(5-methyl-2-furanyl)methyl]-6-nitrophenol | [no description available] | medium | 1 | 0 | nitrophenol | |
| 2-(4-nitrophenyl)-N-(2-oxolanylmethyl)-4-quinazolinamine | [no description available] | medium | 1 | 0 | quinazolines | |
| 2-(4-hydroxy-1,3-thiazol-2-yl)-1-phenylethan-1-one | [no description available] | medium | 1 | 0 | aromatic ketone | |
| Methyl(2-furoylamino)acetic acid | [no description available] | medium | 1 | 0 | N-acyl-amino acid | |
| 5-nitro-8-(1-pyrrolidinyl)quinoline | [no description available] | medium | 1 | 0 | nitro compound;
quinolines | |
| 2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)-N-phenylacetamide | [no description available] | medium | 1 | 0 | amino acid amide | |
| 2-[(4-methylphenyl)sulfonylamino]pentanoic acid | [no description available] | medium | 1 | 0 | sulfonamide | |
| 4,6-dimorpholino-n-(4-nitrophenyl)-1,3,5-triazin-2-amine | [no description available] | medium | 1 | 0 | | |
| 1-[(3-chlorophenyl)methyl]-N,N-diethyl-3-piperidinecarboxamide | [no description available] | medium | 1 | 0 | piperidines | |
| 1-(2,6-dimethyl-1-piperidinyl)-2-phenylethanone | [no description available] | medium | 1 | 0 | acetamides | |
| 2-amino-7-methyl-5-oxo-4-(2,3,4-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| 3-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-1-phenylpyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 1-(4-bromophenyl)-3-(diethylamino)pyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 4-(5,6-diphenyl-1,2,4-triazin-3-yl)morpholine | [no description available] | medium | 1 | 0 | dialkylarylamine;
tertiary amino compound | |
| (3,5-Dimethyl-1-adamantyl)amine nitrate | [no description available] | medium | 1 | 0 | nitrates | |
| 1-(4-tert-butylphenoxy)-3-(1H-1,2,4-triazol-5-ylthio)-2-propanol | [no description available] | medium | 1 | 0 | alkylbenzene | |
| N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-2-adamantanamine | [no description available] | medium | 1 | 0 | N-alkylpyrrolidine | |
| 4-phenyl-N-(pyridin-4-ylmethyl)-2-butanamine | [no description available] | medium | 1 | 0 | aralkylamine | |
| N-(5-nitro-2-pyridinyl)cyclopropanecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| 3-[(4-bromophenyl)methyl]-4-(4-methoxyanilino)-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | anilide | |
| 3-ethyl-N-(2H-tetrazol-5-yl)-1-adamantanecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| N-(4-propan-2-ylphenyl)-3-bicyclo[2.2.1]heptanecarboxamide | [no description available] | medium | 1 | 0 | monoterpenoid | |
| 4-chloro-N-[2-(4-nitroanilino)ethyl]benzamide | [no description available] | medium | 1 | 0 | carbonyl compound;
organohalogen compound | |
| 2-[(2,3-dihydro-1,4-benzodioxin-6-ylamino)-oxomethyl]-1-cyclohexanecarboxylic acid | [no description available] | medium | 1 | 0 | benzodioxine | |
| 2,4-dichloro-6-[1-(4-morpholinyl)-3-phenylprop-2-ynyl]phenol | [no description available] | medium | 1 | 0 | aromatic compound | |
| 2-[[1-(4-ethoxyphenyl)-2,5-dioxo-3-pyrrolidinyl]amino]acetonitrile | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 1-ethoxy-3-(2-methoxy-4-prop-2-enylphenoxy)-2-propanol | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| 6-amino-4-(3-chlorophenyl)-3-methyl-1-(phenylmethyl)-4H-pyrano[2,3-c]pyrazole-5-carbonitrile | [no description available] | medium | 1 | 0 | organochlorine compound;
pyranopyrazole | |
| 1-(2-chlorophenoxy)-3-(2-methyl-1-benzimidazolyl)-2-propanol | [no description available] | medium | 1 | 0 | benzimidazoles | |
| N-[2-furanyl-(8-hydroxy-7-quinolinyl)methyl]-2-methylpropanamide | [no description available] | medium | 1 | 0 | hydroxyquinoline | |
| N-(2-hydroxy-5-methylphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide;
furans | |
| 4-amino-7,8,9,10-tetrahydro-6H-pyrimido[3,4]pyrrolo[3,5-a]azepine-11-carbonitrile | [no description available] | medium | 1 | 0 | organic heterobicyclic compound;
organonitrogen heterocyclic compound | |
| 1-(3,5-dimethylphenyl)-3-(1H-1,2,4-triazol-5-ylthio)pyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 6-[(3,4-difluoroanilino)-oxomethyl]-1-cyclohex-3-enecarboxylic acid | [no description available] | medium | 1 | 0 | anilide | |
| 4-[(3-cyano-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)amino]-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | organosulfur heterocyclic compound | |
| [3-methyl-4-[oxo(thiophen-2-yl)methyl]-1-piperazinyl]-thiophen-2-ylmethanone | [no description available] | medium | 1 | 0 | aromatic amide;
thiophenes | |
| [4-(2-methoxyphenyl)-1-piperazinyl]-[4-[(phenylthio)methyl]phenyl]methanone | [no description available] | medium | 1 | 0 | piperazines | |
| N-(3,3,5-trimethylcyclohexyl)-1H-1,2,4-triazole-5-carboxamide | [no description available] | medium | 1 | 0 | aromatic amide;
heteroarene | |
| 4-[2-nitro-5-[4-(phenylmethyl)sulfonyl-1-piperazinyl]phenyl]morpholine | [no description available] | medium | 1 | 0 | piperazines | |
| 5-(4-ethylsulfonyl-1-piperazinyl)-2-nitro-N-(3-pyridinylmethyl)aniline | [no description available] | medium | 1 | 0 | piperazines | |
| 2-[[5-[(1,3-benzothiazol-2-ylthio)methyl]-4-methyl-1,2,4-triazol-3-yl]thio]-N-[2-(4-morpholinyl)ethyl]acetamide | [no description available] | medium | 1 | 0 | benzothiazoles | |
| N-ethyl-N-[2-[(5-nitro-8-quinolinyl)amino]ethyl]benzenesulfonamide | [no description available] | medium | 1 | 0 | nitro compound;
quinolines | |
| 1-(4-methoxyphenyl)-N-(4-methyl-2-pyridinyl)-5-oxo-3-pyrrolidinecarboxamide | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 3,4,5-trimethoxy-N-[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
| 3-(n,n-dimethylsulfonamido)-4-methyl-nitrobenzene | [no description available] | medium | 1 | 0 | C-nitro compound;
sulfonamide;
toluenes | bone density conservation agent;
EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor;
geroprotector |
| 6,3',4'-Trimethoxyflavanone | [no description available] | medium | 1 | 0 | ether;
flavonoids | |
| 1-[4-(3-ethoxyphenoxy)butyl]imidazole | [no description available] | medium | 1 | 0 | aromatic ether | |
| 5-[[(1-cyclohexyl-5-tetrazolyl)thio]methyl]-3-phenyl-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole;
ring assembly | |
| 2-[1-(3,4-dihydro-2H-quinolin-1-yl)-1-oxopropan-2-yl]isoindole-1,3-dione | [no description available] | medium | 1 | 0 | phthalimides | |
| [4-(benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-(2,5-dioxo-1-pyrrolidinyl)-N-(2-methyl-1,3-dioxo-5-isoindolyl)benzamide | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
| 6-[[[5-(ethylthio)-1,3,4-thiadiazol-2-yl]amino]-oxomethyl]-1-cyclohex-3-enecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic amide | |
| 2,5-dimethoxy-n-(quinolin-3-yl)benzenesulfonamide | [no description available] | medium | 1 | 0 | quinolines | |
| LSM-25805 | [no description available] | medium | 1 | 0 | isoindoles | |
| 4-ethoxy-N-(3-quinolinyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | quinolines | |
| 3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide | [no description available] | medium | 1 | 0 | 1-benzothiophenes | |
| nsc 727447 | [no description available] | medium | 1 | 0 | | |
| 2-methoxy-N-[(4-methylphenyl)methyl]-2-phenylacetamide | [no description available] | medium | 1 | 0 | acetamides | |
| 2-(4-chlorophenoxy)-N-(5-nitro-2-thiazolyl)acetamide | [no description available] | medium | 1 | 0 | C-nitro compound;
thiazoles | |
| 7-(2-methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine | [no description available] | medium | 1 | 0 | methoxybenzenes | |
| N-[3-[2,5-dioxo-3-(phenylmethyl)-1-pyrrolidinyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | pyrrolidines | |
| 3,4-dimethoxy-N-[3-(methylthio)phenyl]benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
| 3-methyl-4-nitro-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 2-[(4-chlorophenyl)methylthio]-N-(2-hydroxy-5-nitrophenyl)acetamide | [no description available] | medium | 1 | 0 | nitrophenol | |
| 2-(4-ethoxyphenyl)-N-[3-(1-imidazolyl)propyl]-4-quinolinecarboxamide | [no description available] | medium | 1 | 0 | quinolines | |
| N-(4-bromophenyl)-5-methyl-4-nitro-1H-pyrazol-3-amine | [no description available] | medium | 1 | 0 | C-nitro compound | |
| 3,3-bis(4-hydroxyphenyl)-7-methyl-1,3-dihydro-2h-indol-2-one | [no description available] | medium | 1 | 0 | | |
| N-[4-[(cyclohexylamino)-oxomethyl]phenyl]-3-pyridinecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
| N,N,4-trimethyl-2-[[(5-methyl-2-furanyl)-oxomethyl]amino]-5-thiazolecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide;
thiazoles | |
| ex 527 | [no description available] | medium | 1 | 0 | carbazoles;
monocarboxylic acid amide;
organochlorine compound | |
| 3-[3-[(5-ethyl-[1,2,4]triazino[5,6-b]indol-3-yl)thio]propyl]-1H-benzimidazol-2-one | [no description available] | medium | 1 | 0 | indoles | |
| 4-methyl-2,7-diphenyl-8H-pyrido[2,3-d]pyrimidin-5-one | [no description available] | medium | 1 | 0 | phenylpyridine | |
| 3-methylharman | [no description available] | medium | 1 | 0 | | |
| 1-methyl-beta-carboline-3-carboxylic acid | [no description available] | medium | 1 | 0 | | |
| sildenafil | [no description available] | medium | 1 | 0 | piperazines;
pyrazolopyrimidine;
sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent |
| 2-methyl-4(3h)-quinazolinone | [no description available] | medium | 1 | 0 | | |
| n(4)-desoxychlordiazepoxide | [no description available] | medium | 1 | 0 | | |
| 2-amino-3-hydroxyphenazine | [no description available] | medium | 1 | 0 | | |
| 2-styrylquinazolin-4(3h)-one | [no description available] | medium | 1 | 0 | | |
| 2-amino-5-iodo-6-phenyl-4-pyrimidinone | [no description available] | medium | 1 | 0 | | |
| quininib | [no description available] | medium | 1 | 0 | phenols;
styrylquinoline | angiogenesis inhibitor |
| bropirimine | [no description available] | medium | 1 | 0 | pyrimidines | |
| 2-[(6-ethyl-4-methyl-2-quinazolinyl)amino]-1H-quinazolin-4-one | [no description available] | medium | 1 | 0 | quinazolines | |
| 2-[(6-ethyl-4-methyl-2-quinazolinyl)amino]-6-(methoxymethyl)-1H-pyrimidin-4-one | [no description available] | medium | 1 | 0 | quinazolines | |
| salubrinal | [no description available] | medium | 1 | 0 | aminal;
organochlorine compound;
quinolines;
secondary carboxamide;
thioureas | |
| pilocarpine | [no description available] | medium | 1 | 0 | pilocarpine | antiglaucoma drug |
| cyclosporine | [no description available] | medium | 1 | 0 | | |
| dithizone | [no description available] | medium | 2 | 0 | | |
| acetazolamide | [no description available] | low | 0 | 0 | monocarboxylic acid amide;
sulfonamide;
thiadiazoles | anticonvulsant;
diuretic;
EC 4.2.1.1 (carbonic anhydrase) inhibitor |
| 1-(4-methanesulfonamidophenoxy)-3-(n-methyl-3,4-dichlorophenylethylamino)-2-propanol | [no description available] | low | 0 | 0 | sulfonamide | |
| amosulalol | [no description available] | low | 0 | 0 | sulfonamide | |
| ampiroxicam | [no description available] | low | 0 | 0 | acetal;
aminopyridine;
benzothiazine;
etabonate ester;
monocarboxylic acid amide;
sulfonamide | analgesic;
antirheumatic drug;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug;
prodrug |
| amsacrine | [no description available] | low | 0 | 0 | acridines;
aromatic ether;
sulfonamide | antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor |
| azosemide | [no description available] | low | 0 | 0 | monochlorobenzenes;
sulfonamide;
tetrazoles;
thiophenes | loop diuretic |
| bendroflumethiazide | [no description available] | low | 0 | 0 | benzothiadiazine;
sulfonamide | antihypertensive agent;
diuretic |
| benzothiazide | [no description available] | low | 0 | 0 | benzothiadiazine;
sulfonamide | antihypertensive agent;
diuretic |
| benzylhydrochlorothiazide | [no description available] | low | 0 | 0 | benzenes;
benzothiadiazine;
organochlorine compound;
secondary amino compound;
sulfonamide | |
| bumetanide | [no description available] | low | 0 | 0 | amino acid;
benzoic acids;
sulfonamide | diuretic;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor |
| celecoxib | [no description available] | low | 0 | 0 | organofluorine compound;
pyrazoles;
sulfonamide;
toluenes | cyclooxygenase 2 inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug |
| chlorthalidone | [no description available] | low | 0 | 0 | isoindoles;
monochlorobenzenes;
sulfonamide | |
| 4-chloro-N-(2,6-dimethyl-1-piperidinyl)-3-sulfamoylbenzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| dichlorphenamide | [no description available] | low | 0 | 0 | dichlorobenzene;
sulfonamide | antiglaucoma drug;
EC 4.2.1.1 (carbonic anhydrase) inhibitor;
ophthalmology drug |
| e 4031 | [no description available] | low | 0 | 0 | sulfonamide | |
| ethoxzolamide | [no description available] | low | 0 | 0 | aromatic ether;
benzothiazoles;
sulfonamide | antiglaucoma drug;
diuretic;
EC 4.2.1.1 (carbonic anhydrase) inhibitor |
| famotidine | [no description available] | low | 0 | 0 | 1,3-thiazoles;
guanidines;
sulfonamide | anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor |
| furosemide | [no description available] | low | 0 | 0 | chlorobenzoic acid;
furans;
sulfonamide | environmental contaminant;
loop diuretic;
xenobiotic |
| glimepiride | [no description available] | low | 0 | 0 | sulfonamide | |
| n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide | [no description available] | low | 0 | 0 | isoquinolines;
sulfonamide | |
| N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | [no description available] | low | 0 | 0 | bromobenzenes;
isoquinolines;
olefinic compound;
secondary amino compound;
sulfonamide | EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor |
| hydrochlorothiazide | [no description available] | low | 0 | 0 | benzothiadiazine;
organochlorine compound;
sulfonamide | antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic |
| hydroxymethyltolbutamide | [no description available] | low | 0 | 0 | benzyl alcohols;
sulfonamide;
ureas | metabolite |
| indapamide | [no description available] | low | 0 | 0 | indoles;
organochlorine compound;
sulfonamide | antihypertensive agent;
diuretic |
| methazolamide | [no description available] | low | 0 | 0 | sulfonamide;
thiadiazoles | |
| metolazone | [no description available] | low | 0 | 0 | organochlorine compound;
quinazolines;
sulfonamide | antihypertensive agent;
diuretic;
ion transport inhibitor |
| monodansylcadaverine | [no description available] | low | 0 | 0 | aminonaphthalene;
primary amino compound;
sulfonamide;
tertiary amino compound | EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor;
fluorochrome;
protective agent |
| n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide | [no description available] | low | 0 | 0 | naphthalenes;
organochlorine compound;
primary amino compound;
sulfonamide | |
| naratriptan | [no description available] | low | 0 | 0 | heteroarylpiperidine;
sulfonamide;
tryptamines | serotonergic agonist;
vasoconstrictor agent |
| nimesulide | [no description available] | low | 0 | 0 | aromatic ether;
C-nitro compound;
sulfonamide | cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug |
| n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | [no description available] | low | 0 | 0 | aromatic ether;
C-nitro compound;
sulfonamide | antineoplastic agent;
cyclooxygenase 2 inhibitor |
| 5-[3-(benzenesulfonamido)phenyl]-N-hydroxypent-2-en-4-ynamide | [no description available] | low | 0 | 0 | sulfonamide | |
| phthalylsulfathiazole | [no description available] | low | 0 | 0 | 1,3-thiazoles;
dicarboxylic acid monoamide;
sulfonamide antibiotic;
sulfonamide | |
| probenecid | [no description available] | low | 0 | 0 | benzoic acids;
sulfonamide | uricosuric drug |
| sulfadiazine | [no description available] | low | 0 | 0 | pyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide | antiinfective agent;
antimicrobial agent;
antiprotozoal drug;
coccidiostat;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
xenobiotic |
| sotalol | [no description available] | low | 0 | 0 | ethanolamines;
secondary alcohol;
secondary amino compound;
sulfonamide | anti-arrhythmia drug;
beta-adrenergic antagonist;
environmental contaminant;
xenobiotic |
| SU6656 | [no description available] | low | 0 | 0 | oxindoles;
sulfonamide | antineoplastic agent;
Aurora kinase inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor |
| sulfabenzamide | [no description available] | low | 0 | 0 | benzenes;
sulfonamide antibiotic;
sulfonamide | antibacterial drug;
antimicrobial drug |
| sulfacytine | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| sulfamerazine | [no description available] | low | 0 | 0 | pyrimidines;
sulfonamide antibiotic;
sulfonamide | antiinfective agent;
drug allergen |
| sulfameter | [no description available] | low | 0 | 0 | pyrimidines;
sulfonamide antibiotic;
sulfonamide | antiinfective agent;
leprostatic drug;
renal agent |
| sulfamethizole | [no description available] | low | 0 | 0 | sulfonamide antibiotic;
sulfonamide;
thiadiazoles | antiinfective agent;
antimicrobial agent;
drug allergen;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor |
| sulfamethoxazole | [no description available] | low | 0 | 0 | isoxazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide | antibacterial agent;
antiinfective agent;
antimicrobial agent;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
epitope;
P450 inhibitor;
xenobiotic |
| sulfamethoxypyridazine | [no description available] | low | 0 | 0 | pyridazines;
sulfonamide antibiotic;
sulfonamide | antiinfective agent;
drug allergen;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor |
| sulfamonomethoxine | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| sulfanilamide | [no description available] | low | 0 | 0 | substituted aniline;
sulfonamide antibiotic;
sulfonamide | antibacterial agent;
drug allergen;
EC 4.2.1.1 (carbonic anhydrase) inhibitor |
| sulfanitran | [no description available] | low | 0 | 0 | sulfonamide | |
| sulfaphenazole | [no description available] | low | 0 | 0 | primary amino compound;
pyrazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide | antibacterial drug;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor;
P450 inhibitor |
| sulfapyridine | [no description available] | low | 0 | 0 | pyridines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide | antiinfective agent;
dermatologic drug;
drug allergen;
environmental contaminant;
xenobiotic |
| sulfaquinoxaline | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| sulfisomidine | [no description available] | low | 0 | 0 | pyrimidines;
sulfonamide antibiotic;
sulfonamide | antiinfective agent |
| sulfisoxazole | [no description available] | low | 0 | 0 | isoxazoles;
sulfonamide antibiotic;
sulfonamide | antibacterial drug;
drug allergen |
| sulfoxone | [no description available] | low | 0 | 0 | sulfonamide | |
| sulpiride | [no description available] | low | 0 | 0 | benzamides;
N-alkylpyrrolidine;
sulfonamide | antidepressant;
antiemetic;
antipsychotic agent;
dopaminergic antagonist |
| sumatriptan | [no description available] | low | 0 | 0 | sulfonamide;
tryptamines | serotonergic agonist;
vasoconstrictor agent |
| delavirdine | [no description available] | low | 0 | 0 | aminopyridine;
indolecarboxamide;
N-acylpiperazine;
sulfonamide | antiviral drug;
HIV-1 reverse transcriptase inhibitor |
| zonisamide | [no description available] | low | 0 | 0 | 1,2-benzoxazoles;
sulfonamide | anticonvulsant;
antioxidant;
central nervous system drug;
protective agent;
T-type calcium channel blocker |
| 4-toluenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| n-methyl-n-nitrosotoluene-p-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| sulfachlorpyridazine | [no description available] | low | 0 | 0 | organochlorine compound;
pyridazines;
sulfonamide | antibacterial drug;
drug allergen;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor |
| acetyl sulfisoxazole | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| sulfaethidole | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| sulfalene | [no description available] | low | 0 | 0 | pyrazines;
sulfonamide antibiotic;
sulfonamide | |
| thioproperazine | [no description available] | low | 0 | 0 | N-alkylpiperazine;
N-methylpiperazine;
phenothiazines;
sulfonamide | phenothiazine antipsychotic drug |
| carbutamide | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| glymidine | [no description available] | low | 0 | 0 | diether;
pyrimidines;
sulfonamide | hypoglycemic agent |
| thiazosulfone | [no description available] | low | 0 | 0 | sulfonamide | |
| glybuthiazol | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| sulfanilylurea | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| metahexamide | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| clopamide | [no description available] | low | 0 | 0 | sulfonamide | |
| tolcyclamide | [no description available] | low | 0 | 0 | sulfonamide | |
| sulfamoxole | [no description available] | low | 0 | 0 | oxazole;
sulfonamide antibiotic;
sulfonamide | antimicrobial agent;
drug allergen |
| sulfaethoxypyridazine | [no description available] | low | 0 | 0 | sulfonamide | antibacterial agent |
| 4-((diethylamino)sulfonyl)benzoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| dinsed | [no description available] | low | 0 | 0 | sulfonamide | |
| amidephrine | [no description available] | low | 0 | 0 | sulfonamide | |
| sulfadoxine | [no description available] | low | 0 | 0 | pyrimidines;
sulfonamide | antibacterial drug;
antimalarial |
| hydroxyhexamide | [no description available] | low | 0 | 0 | sulfonamide | |
| asulam | [no description available] | low | 0 | 0 | carbamate ester;
primary amino compound;
substituted aniline;
sulfonamide | agrochemical;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
herbicide;
xenobiotic |
| oryzalin | [no description available] | low | 0 | 0 | aromatic amine;
C-nitro compound;
sulfonamide;
tertiary amino compound | agrochemical;
antimitotic;
herbicide |
| glisoxepide | [no description available] | low | 0 | 0 | sulfonamide | |
| perfluidone | [no description available] | low | 0 | 0 | sulfonamide | |
| mefluidide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-aminosulfonyl-benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester;
methyl ester;
sulfonamide | marine xenobiotic metabolite |
| clorsulon | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| agreal | [no description available] | low | 0 | 0 | sulfonamide | |
| n-acetylsulfapyridine | [no description available] | low | 0 | 0 | sulfonamide | |
| tirofiban | [no description available] | low | 0 | 0 | L-tyrosine derivative;
piperidines;
sulfonamide | anticoagulant;
fibrin modulating drug;
platelet glycoprotein-IIb/IIIa receptor antagonist |
| amprenavir | [no description available] | low | 0 | 0 | carbamate ester;
sulfonamide;
tetrahydrofuryl ester | antiviral drug;
HIV protease inhibitor |
| n(4)-acetylsulfamethoxazole | [no description available] | low | 0 | 0 | isoxazoles;
sulfonamide | drug metabolite;
marine xenobiotic metabolite |
| glisentide | [no description available] | low | 0 | 0 | sulfonamide | |
| ebrotidine | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-chlorobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-amino-6-chloro-1,3-benzenedisulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N(4)-acetylsulfathiazole | [no description available] | low | 0 | 0 | 1,3-thiazoles;
acetamides;
sulfonamide | marine xenobiotic metabolite |
| 2-benzothiazolesulfonamide | [no description available] | low | 0 | 0 | benzothiazoles;
sulfonamide | |
| brinzolamide | [no description available] | low | 0 | 0 | sulfonamide;
thienothiazine | antiglaucoma drug;
EC 4.2.1.1 (carbonic anhydrase) inhibitor |
| piloty's acid | [no description available] | low | 0 | 0 | sulfonamide | |
| perfluorooctanesulfonamide | [no description available] | low | 0 | 0 | perfluorinated compound;
sulfonamide | persistent organic pollutant |
| uk 68798 | [no description available] | low | 0 | 0 | aromatic ether;
sulfonamide;
tertiary amino compound | anti-arrhythmia drug;
potassium channel blocker |
| glyclopyramide | [no description available] | low | 0 | 0 | sulfonamide | |
| fluoresone | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-aminobenzenesulfonamide | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| 4-chloro-5-sulfamoylanthranilic acid | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| sulfluramid | [no description available] | low | 0 | 0 | sulfonamide | acaricide;
environmental contaminant;
insecticide;
xenobiotic |
| n-(2,4-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1h-1,2,4-triazol-1-yl)phenyl)methanesulfonamide | [no description available] | low | 0 | 0 | dichlorobenzene;
organofluorine compound;
sulfonamide;
triazoles | agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide |
| cloransulam-methyl | [no description available] | low | 0 | 0 | methyl ester;
monochlorobenzenes;
organofluorine compound;
sulfonamide;
triazolopyrimidines | agrochemical;
EC 2.2.1.6 (acetolactate synthase) inhibitor;
herbicide |
| sdds | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| 4-chlorobenzenesulfonylurea | [no description available] | low | 0 | 0 | sulfonamide | |
| n-(2,6-difluorophenyl)-5-methyl(1,2,4)-triazol(1,5-a)pyrimidine-2-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| flazasulfuron | [no description available] | low | 0 | 0 | pyridines;
sulfonamide | |
| bosentan anhydrous | [no description available] | low | 0 | 0 | primary alcohol;
pyrimidines;
sulfonamide | antihypertensive agent;
endothelin receptor antagonist |
| sulfamethoxazole hydroxylamine | [no description available] | low | 0 | 0 | isoxazoles;
sulfonamide | allergen;
metabolite |
| gr 113808 | [no description available] | low | 0 | 0 | indolyl carboxylate ester;
piperidines;
sulfonamide | serotonergic antagonist |
| valdecoxib | [no description available] | low | 0 | 0 | isoxazoles;
sulfonamide | antipyretic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug |
| ym 12617 | [no description available] | low | 0 | 0 | aromatic ether;
secondary amino compound;
sulfonamide | |
| dansyllysine | [no description available] | low | 0 | 0 | L-lysine derivative;
non-proteinogenic L-alpha-amino acid;
sulfonamide | epitope |
| almotriptan | [no description available] | low | 0 | 0 | indoles;
sulfonamide;
tertiary amine | non-steroidal anti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent |
| 4-nitrososulfamethoxazole | [no description available] | low | 0 | 0 | isoxazoles;
nitroso compound;
sulfonamide | allergen;
metabolite |
| cki 7 | [no description available] | low | 0 | 0 | isoquinolines;
organochlorine compound;
primary amino compound;
sulfonamide | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor |
| fosamprenavir | [no description available] | low | 0 | 0 | sulfonamide | prodrug |
| metipamide | [no description available] | low | 0 | 0 | sulfonamide | |
| jte 522 | [no description available] | low | 0 | 0 | 1,3-oxazoles;
organofluorine compound;
sulfonamide | cyclooxygenase 2 inhibitor |
| carboxytolbutamide | [no description available] | low | 0 | 0 | sulfonamide | |
| tevenel | [no description available] | low | 0 | 0 | sulfonamide | |
| sulfachlorpyrazine | [no description available] | low | 0 | 0 | sulfonamide | |
| n(4)-acetylsulfadimethoxine | [no description available] | low | 0 | 0 | acetamides;
pyrimidines;
sulfonamide | marine xenobiotic metabolite |
| dronedarone | [no description available] | low | 0 | 0 | 1-benzofurans;
aromatic ether;
aromatic ketone;
sulfonamide;
tertiary amino compound | anti-arrhythmia drug;
environmental contaminant;
xenobiotic |
| darunavir | [no description available] | low | 0 | 0 | carbamate ester;
furofuran;
sulfonamide | antiviral drug;
HIV protease inhibitor |
| cimicoxib | [no description available] | low | 0 | 0 | aromatic ether;
imidazoles;
organochlorine compound;
organofluorine compound;
sulfonamide | cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug |
| dabuzalgron | [no description available] | low | 0 | 0 | aromatic ether;
imidazoles;
monochlorobenzenes;
sulfonamide | alpha-adrenergic agonist |
| n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide | [no description available] | low | 0 | 0 | chloroindole;
organochlorine compound;
sulfonamide | antineoplastic agent;
EC 4.2.1.1 (carbonic anhydrase) inhibitor |
| 3,4-Dichlorobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-cyclooctyl-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| tolpyrramide | [no description available] | low | 0 | 0 | sulfonamide | |
| acetic acid [2-[acetyl-(4-methylphenyl)sulfonylamino]phenyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| tosylphenylalanyl chloromethyl ketone | [no description available] | low | 0 | 0 | alpha-chloroketone;
sulfonamide | alkylating agent;
serine proteinase inhibitor |
| rosuvastatin | [no description available] | low | 0 | 0 | dihydroxy monocarboxylic acid;
monofluorobenzenes;
pyrimidines;
statin (synthetic);
sulfonamide | anti-inflammatory agent;
antilipemic drug;
cardioprotective agent;
CETP inhibitor;
environmental contaminant;
xenobiotic |
| bms 214662 | [no description available] | low | 0 | 0 | benzenes;
benzodiazepine;
imidazoles;
nitrile;
sulfonamide;
thiophenes | antineoplastic agent;
apoptosis inducer;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor |
| prinomastat | [no description available] | low | 0 | 0 | aromatic ether;
hydroxamic acid;
pyridines;
sulfonamide;
thiomorpholines | antineoplastic agent;
EC 3.4.24.35 (gelatinase B) inhibitor;
matrix metalloproteinase inhibitor |
| glucosulfone | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[1-(benzenesulfonyl)-3-pyrrolyl]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-bromo-2,5-dimethoxyphenyl)sulfonylazepane | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-chloro-3-methoxyphenyl)sulfonylazepane | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-[(4-methylphenyl)sulfonyl]-6-azabicyclo[3.2.1]octane | [no description available] | low | 0 | 0 | sulfonamide | |
| N-cyclopentyl-4-[[4-[2-furanyl(oxo)methyl]-1-piperazinyl]sulfonyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N4-cyclohexyl-N1-ethyl-N4-(2-pyridinylmethyl)benzene-1,4-disulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[cyclohexyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(3-chloro-4-methoxyphenyl)sulfonyl-N-(3-pyridinyl)-3-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(3-ethoxyphenyl)-1-(4-methoxyphenyl)sulfonyl-3-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[[4-(4-methylphenyl)sulfonyl-1,4-diazepan-1-yl]sulfonyl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[2-[1-(4-methoxyphenyl)sulfonyl-2-benzimidazolyl]ethyl]morpholine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,5-dimethoxyphenyl)sulfonyl-N-(phenylmethyl)-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[2-chloro-5-(trifluoromethyl)phenyl]sulfonylazepane | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[4-[(5,6-dimethyl-1-benzimidazolyl)sulfonyl]phenyl]sulfonylmorpholine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(4-methoxyphenyl)sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-methyl-N-(pyridin-4-ylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-cyclopropyl-4-(2,3-dihydroindol-1-ylsulfonyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[4-(benzenesulfonyl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-furanylmethyl)-2-[(4-methoxyphenyl)sulfonylamino]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(diethylsulfamoyl)phenyl]-2-(2-oxo-1,3-benzothiazol-3-yl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[[4-(1-benzotriazolyl)-1-piperidinyl]sulfonyl]-N-cyclopentylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N,N-dimethyl-4-[[4-(5-methyl-1-benzotriazolyl)-1-piperidinyl]sulfonyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(4-methoxyphenyl)sulfonyl-N-(phenylmethyl)-1-piperazinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(4-fluorophenyl)-2-thiazolyl]-2-[(4-methylphenyl)sulfonylamino]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(4-{[2-(pyridin-3-yl)piperidin-1-yl]sulfonyl}phenyl)acetamide | [no description available] | low | 0 | 0 | acetamides;
piperidines;
pyridines;
sulfonamide | |
| 3,4,5-trimethoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(4-phenylmethoxyphenyl)methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(diethylsulfamoyl)-N-(1,3,4-thiadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-fluoro-3-methylphenyl)sulfonylamino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-furanylmethyl)-4-methyl-N-(phenylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(2-ethylphenoxy)-N-(4-sulfamoylphenyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-chlorophenyl)-3-(4-sulfamoylphenyl)urea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(3-chloro-4-hydroxy-2,5-dimethylphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,4,6-trimethyl-n-(meta-3-trifluoromethylphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(1-cyclohexenyl)ethyl]-2,5-dimethoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1-ethyl-5-benzimidazolyl)-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-methyl-N-(5,6,7,8-tetrahydronaphthalen-1-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-chloro-N-(4-hydrazinyl-6-methyl-2-pyrimidinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-amino-N-(4-ethoxyphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| 1-(2-nitrophenyl)sulfonylpiperidine | [no description available] | low | 0 | 0 | sulfonamide | |
| N,4-dimethyl-N-(4-methylphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,3,4-trimethyl-N-(3-pyridinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[4-(1-pyrrolidinylsulfonyl)phenyl]hydrazinylidene]propanedinitrile | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[1-(benzenesulfonyl)-2,2-dichloroethenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-chloro-3-ethoxy-N-(4-ethylphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(3-chlorophenyl)sulfonylpyrrolidine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-cyclopropyl-3-(4-sulfamoylphenyl)thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[3-[methyl(methylsulfonyl)amino]phenyl]-2-phenoxyacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[methyl(methylsulfonyl)amino]-N-(2-phenylethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(2,6-dichloroanilino)-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines;
sulfonamide | |
| 4-(4-chloroanilino)-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines;
sulfonamide | |
| 1-ethyl-3-(4-methylphenyl)sulfonylthiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-chloro-N-(2-hydroxyphenyl)-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines;
sulfonamide | |
| 5-chloro-2-methoxy-N,N,4-trimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(2,5-dimethoxyphenyl)sulfonyl-methylamino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-ethylphenyl)-2-methoxy-5-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-ethoxy-N-(4-fluorophenyl)-2,3-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(1-cyclohexenyl)ethyl]-4-[methyl(methylsulfonyl)amino]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,5-dimethoxyphenyl)sulfonyl-4-ethylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(methylthio)phenyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(4-methoxyphenyl)-4-(methylthio)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-methoxy-5-propan-2-yl-N-(2-pyridinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,3,5,6-tetramethyl-N-(2-methyl-1,3-benzothiazol-5-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[4-chloro-2-methyl-5-(2-pyridinylsulfamoyl)phenoxy]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(3-chlorophenyl)-N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]-2-(3-methyl-N-methylsulfonylanilino)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(5-bromo-2-thiophenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[(2,6-dimethoxy-4-pyrimidinyl)sulfamoyl]phenyl]butanamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(3-pyridinyl)-4-[4-(1-pyrrolidinylsulfonyl)phenyl]thiazole | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-bromo-6-chloro-N-(4-methyl-2-pyridinyl)-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines;
sulfonamide | |
| 4-(4-fluorophenyl)sulfonyl-2-(2-furanyl)-N-phenyl-5-oxazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[4-(4-methylphenyl)sulfonyl-1-piperazinyl]methyl]-4-propan-2-ylphenol | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2-chlorophenyl)methyl]-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-thiophen-2-ylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[methyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(2-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-ethoxyphenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-methylphenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-chlorophenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-(1,1,3-trioxo-1,2-benzothiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(1-piperidinylsulfonyl)phenyl]-2-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1,3-benzothiazol-2-yl)-2-[methyl-(4-methylphenyl)sulfonylamino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-cyclohexyl-3-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(5-chloro-2-hydroxyphenyl)-1,3-dimethyl-2-oxo-5-benzimidazolesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,5-dichloro-4-ethoxy-N-(2-pyridinylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-ethoxy-2,3,5-trimethyl-N-(3-pyridinylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[N-(benzenesulfonyl)-4-ethoxyanilino]-N-(2-methoxyphenyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[(4-chlorophenyl)methyl-methylsulfonylamino]-N-(2-pyridinylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-bromo-2-methoxy-N-(3-methyl-2-pyridinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| pyrabactin | [no description available] | low | 0 | 0 | naphthalenes;
organobromine compound;
pyridines;
sulfonamide | abscisic acid receptor agonist;
hormone;
plant growth regulator |
| 1,4-bis[(4-methoxy-2-methylphenyl)sulfonyl]-1,4-diazepane | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-furanylmethyl)-4-(1-pyrrolidinylsulfonyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(benzenesulfonyl)-N-methyl-N-phenyl-1-piperazinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(3-ethylphenoxy)-N-[4-(2-pyridinylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[[1-(benzenesulfonyl)-4-piperidinyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(1,3-benzodioxol-5-yl)-3-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(1,3-benzodioxol-5-yl)-3-[4-[(phenylmethyl)sulfamoyl]phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| 1,3-diethyl-6-methyl-N-(2-methylphenyl)-2-oxo-5-benzimidazolesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1,3-benzodioxol-5-ylmethyl)-4-methyl-3-(1-piperidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(1-azepanylsulfonyl)-N-(3-isoxazolyl)-4-methylbenzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-methylsulfonyl-N-(6,7,8,9-tetrahydrodibenzofuran-2-yl)-2,3-dihydroindole-5-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[2-chloro-4-(2,3-dihydroindol-1-ylsulfonyl)phenoxy]-N-(2-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-bromo-3-ethoxyphenyl)sulfonyl-3,5-dimethylpyrazole | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(4-hydroxy-3,5-dimethylphenyl)-2,5-dimethyl-3-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-[(5-tert-butyl-2,3-dimethylphenyl)sulfonylamino]-2-hydroxybenzoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-chloro-2,5-dimethoxyphenyl)sulfonylbenzotriazole | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[4-chloro-5-(cyclopentylsulfamoyl)-2-methylphenoxy]-N-cyclohexylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(1,3-benzothiazol-2-ylthio)-N-(4-methylphenyl)sulfonylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,4-dichloro-5-(diethylsulfamoyl)-N-(1,3,4-thiadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[1-(4-tert-butylphenyl)sulfonyl-4-piperidinyl]-6-chloro-1H-benzimidazole | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[5-(1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-[4-(1-pyrrolidinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[[3-[(2-chlorophenyl)methyl]-5-cyclopropyl-7-triazolo[4,5-d]pyrimidinyl]amino]-N,N-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 7-methyl-2-[4-(4-methylphenyl)sulfonyl-1,4-diazepan-1-yl]-3-quinolinecarbonitrile | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-amino-5-(benzenesulfonyl)-2-methoxy-3-pyridinecarbonitrile | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-amino-5-(4-chlorophenyl)sulfonyl-2-oxo-1H-pyridine-3-carbonitrile | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[benzenesulfonyl(2-pyridinyl)amino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-chlorophenyl)sulfonyl-(2-pyridinyl)amino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,5-dichloro-N-(1,5,6-trimethyl-4-benzimidazolyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-[1-(benzenesulfonyl)-3-pyrazolyl]-2-phenylthiazole | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-[1-(4-fluorophenyl)sulfonyl-3-pyrazolyl]-2-phenylthiazole | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[1-[(3,4-dichlorophenyl)methyl]-6-oxo-3-pyridinyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(benzenesulfonylmethyl)-5-(4-chlorophenyl)cyclohexane-1,3-dione | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(benzenesulfonyl)-3-pyrazolidinone | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-methyl-4-pyrazolesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(4-methoxyphenyl)-2-(3-methylphenoxy)-N-(4-methylphenyl)sulfonylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(4-fluorophenyl)-2-thiazolyl]-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[[4-(diethylsulfamoyl)phenyl]-oxomethyl]amino]-4-methyl-5-thiazolecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
| tosylarginine methyl ester | [no description available] | low | 0 | 0 | guanidines;
L-arginine ester;
methyl ester;
sulfonamide | |
| n-(4-(n-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophene-2-yl)acrylamide | [no description available] | low | 0 | 0 | pyrazines;
sulfonamide;
thiophenes | necroptosis inhibitor;
neuroprotective agent |
| N-[(benzenesulfonylhydrazo)-sulfanylidenemethyl]-4-methylbenzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| xl147 | [no description available] | low | 0 | 0 | aromatic amine;
benzothiadiazole;
quinoxaline derivative;
sulfonamide | antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor |
| 7-chloro-2-methyl-4-(4-methylphenyl)sulfonylthiazolo[5,4-b]indole | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(4-methyl-1-piperidinyl)sulfonyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[methyl-(phenylmethyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(4-bromophenyl)sulfonyl-2-(2-furanyl)-5-(methylthio)oxazole | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(4-morpholinylsulfonyl)-N-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-fluorophenyl)thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-methoxy-N-(3-methylbutyl)-3-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1,3-benzothiazol-2-yl)-3-(2,3-dihydroindol-1-ylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1H-benzimidazol-2-yl)-3-[phenyl(prop-2-enyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(4-chlorophenyl)sulfonyl-1-piperazinyl]-2-[(5,7-dimethyl-[1,2,4]triazolo[4,3-a]pyrimidin-3-yl)thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[4-(4-morpholinylsulfonyl)phenyl]propanoic acid [2-[(5-chloro-2-pyridinyl)amino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(5-chloro-2-thiophenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,5-difluoro-N-[2-(4-morpholinylmethyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-3-[methyl-(4-methylphenyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-methyl-1,3-benzothiazol-6-yl)-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[(4-acetyl-1-piperazinyl)sulfonyl]-N-(1H-benzimidazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[(3-hydroxy-5-benzotriazolyl)sulfonylamino]benzoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[(5-chloro-2,4-dimethoxyphenyl)-methylsulfamoyl]-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(2-fluorophenoxy)-N-[4-(2-furanylmethylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[[[5-[3-(1-piperidinylsulfonyl)phenyl]-1,3,4-oxadiazol-2-yl]thio]methyl]-1,2,3-benzotriazin-4-one | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1H-benzimidazol-2-yl)-3-[methyl-(4-methylphenyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,6-dichloro-N-[2-(methylthio)-1,3-benzothiazol-6-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-fluoro-3-methoxy-N-(2-pyridinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(5-ethyl-1,3,4-oxadiazol-2-yl)-4-[methyl(phenyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[bis(2-methoxyethyl)sulfamoyl]-N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(dipropylsulfamoyl)-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[butyl(methyl)sulfamoyl]-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[ethyl-(phenylmethyl)sulfamoyl]-N-(5-methyl-1,3,4-oxadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[ethyl-(phenylmethyl)sulfamoyl]-N-[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[bis(2-methylpropyl)sulfamoyl]-N-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-methyl-2-thiazolyl)thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-4-nitrobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(5-butyl-1H-1,2,4-triazol-3-yl)thio]-N-(4-sulfamoylphenyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-ethoxy-N-[4-(2-pyrimidinylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(dibutylsulfamoyl)phenyl]-2-thiophen-2-ylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,3-dichloro-4-methoxy-N-(3-methoxypropyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(3-cyano-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-2-yl)thio]-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-furanylmethyl)-2-[4-(propylsulfamoyl)phenoxy]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-methyl-N-[2-(phenylmethyl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[4-chloro-5-(cyclohexylsulfamoyl)-2-methylphenoxy]-N-(1,3,4-thiadiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(cyclohexylthio)ethyl]-4-methyl-3-[(4-methylphenyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(3-chlorophenyl)-3-[3-[methyl(methylsulfonyl)amino]phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(cyanomethyl)phenyl]-4-cyclohexylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(4-ethoxyphenyl)-4-[[4-(methylthio)phenyl]sulfonylamino]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(methanesulfonamido)-N-[2-(phenylmethylthio)ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-fluorophenyl)-4-methoxy-2,5-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[benzenesulfonyl-(phenylmethyl)amino]-N-ethylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[benzenesulfonyl(methyl)amino]-N-[2-[(4-chlorophenyl)methylthio]ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(3,4-dimethyl-2-sulfanylidene-5-thiazolyl)carbamic acid 2-[(2,5-dimethylphenyl)sulfonylamino]ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[cyclohexyl-(4-methylphenyl)sulfonylamino]-N-(3-methoxypropyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1H-benzimidazol-2-yl)-4-(dimethylsulfamoyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(3-chlorophenyl)-3-[2-(thiophen-2-ylsulfonylamino)phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[4-methyl-3-(1-piperidinylsulfonyl)phenyl]-1,2-benzothiazol-3-one | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1H-benzimidazol-2-ylmethyl)-3-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-fluoro-2-methylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-cyanophenyl)methylthio]-N-(2-methoxyphenyl)-1,3-benzoxazole-5-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-[4-(4-morpholinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(1-azepanylsulfonyl)-4-chloro-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| sr 3335 | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1H-benzimidazol-2-ylmethyl)-4-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-chlorophenyl)methylthio]-5-[3-(1-piperidinylsulfonyl)phenyl]-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-chloro-3-[(4-chlorophenyl)sulfamoyl]-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2-fluorophenyl)-1-cyclopentanecarboxylic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[(4-methyl-1-piperazinyl)sulfonyl]-N-(4-phenyl-2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-methoxyphenyl)-2-(2-oxopropylthio)-1,3-benzoxazole-5-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[5-(1-pyrrolidinylsulfonyl)-2-thiophenyl]-N-[2-(4-sulfamoylphenyl)ethyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-fluorophenyl)-1-cyclopentanecarboxylic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(2-chlorophenyl)sulfonylpropanoic acid [2-[(3,5-dichloro-6-methyl-2-pyridinyl)amino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[4-[benzenesulfonyl(methyl)amino]phenoxy]-N-(1,3-benzothiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(6-methoxy-1,3-benzothiazol-2-yl)-3-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-cyclopentyl-3,4-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-amino-1-(2-methoxyethyl)-N-(4-methylphenyl)sulfonyl-2,4-dioxo-5-pyrimidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(benzenesulfonyl)propanoic acid [2-[(3,5-dichloro-4-methyl-2-pyridinyl)amino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[[2-cyanoethyl(methyl)amino]-sulfanylidenemethyl]-4-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| [4-methoxy-3-(4-morpholinylsulfonyl)phenyl]-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methanone | [no description available] | low | 0 | 0 | sulfonamide | |
| [4-(4-bromo-2-chlorophenyl)sulfonyl-1-piperazinyl]-(2-sulfanylidene-1H-pyridin-3-yl)methanone | [no description available] | low | 0 | 0 | sulfonamide | |
| [1-(4-fluorophenyl)sulfonyl-4-piperidinyl]-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methanone | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(1S)-1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(3-chloro-2,4,6-trifluorophenyl)sulfonyl-1-piperazinyl]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(4-methoxyphenyl)-N-[4-(2-pyrimidinylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N1-[4-(aminosulfonyl)phenyl]-2,2-dimethylpropanamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(benzenesulfonylmethyl)-5-(4-methoxyphenyl)cyclohexane-1,3-dione | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[bis(2-methylpropoxy)phosphoryl]-3,3,3-trifluoro-2-[(4-methylphenyl)sulfonylamino]propanoic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
| N1-{3-[2-(2-pyridyl)ethyl]phenyl}-4-chlorobenzene-1-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| ethyl 1-[4-(4-chlorobenzenesulfonamido)phenyl]-5-(trifluoromethyl)pyrazole-4-carboxylate | [no description available] | low | 0 | 0 | ethyl ester;
monochlorobenzenes;
organofluorine compound;
pyrazoles;
sulfonamide | |
| 2,3-dichloro-N'-[4-(trifluoromethyl)-2-pyrimidinyl]benzenesulfonohydrazide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-ethyl-2-pyridinyl)-3-(4-methylphenyl)sulfonylurea | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(3,5-dimethylphenyl)-3-[5-(dimethylsulfamoyl)-2-methylphenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-{5-[(dimethylamino)sulfonyl]-2-methylphenyl}cyclohexanecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-tert-butyl-3-[(4-methylphenyl)sulfonylamino]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-methyl-4,7-bis(methylsulfonyl)-3a,5,6,7a-tetrahydro-1H-imidazo[4,5-b]pyrazin-2-one | [no description available] | low | 0 | 0 | imidazopyrazine;
sulfonamide;
ureas | |
| N-(3-acetyl-2-methyl-5-benzofuranyl)-N-(4-chloro-3-nitrophenyl)sulfonylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-chlorophenyl)thio]-N-[4-[(2,4-dimethylphenyl)sulfamoyl]phenyl]propanamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-chloro-N-[2-(4-morpholinyl)cyclohexyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[3-(2-furanyl)-3-phenylpropyl]-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(butylsulfamoyl)phenyl]-2-phenyl-2-(phenylthio)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2,6-dimethyl-3-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N,4-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[4-(1-adamantyl)-N-methylsulfonylanilino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-thiazolyl]-2,3-dihydro-1,4-benzodioxin-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(5-(4-methoxyphenyl)-3-phenyl-4,5-dihydro-1h-pyrazol-1-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[oxo-[1-(2,4,6-trimethylphenyl)sulfonyl-4-piperidinyl]methyl]-1-piperazinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
| N,4-dimethyl-N-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(1-phenylethyl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[1-(4-chlorophenyl)sulfonyl-2-pyrrolidinyl]-4-methyl-1-piperazinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[[1-(2-methylpropyl)-2-benzimidazolyl]thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[(4-hydroxyphenyl)-methylsulfamoyl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-(2,3-dihydro-1,4-benzodioxin-3-ylmethylamino)-N-ethyl-N-phenyl-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines;
sulfonamide | |
| 4-chloro-N-(1-propyl-2-benzimidazolyl)-3-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,3-dihydro-1,4-benzodioxin-3-yl-[4-(3,4-dimethylphenyl)sulfonyl-1-piperazinyl]methanone | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1-propyl-2-benzimidazolyl)-3-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(benzenesulfonyl)-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-nitrophenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
| sulfatolamide | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| e 7010 | [no description available] | low | 0 | 0 | sulfonamide | |
| deracoxib | [no description available] | low | 0 | 0 | organofluorine compound;
pyrazoles;
sulfonamide | cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug |
| diclosulam | [no description available] | low | 0 | 0 | sulfonamide | |
| benzene-1-3-disulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-[(2-chloro-1-oxopropyl)hydrazo]-2-oxoethyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-nitro-N-(pyridin-4-ylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[2-[(4-acetamidophenyl)sulfonylamino]-4-thiazolyl]acetic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[3-(benzenesulfonyl)-2-(1-piperidinyl)propyl]piperidine | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-(2-furanyl)-4-[4-(methanesulfonamido)phenyl]-2-oxo-1-cyclohex-3-enecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(benzenesulfonyl)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]propanamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2-furanylmethyl)-3-[[[4-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| N1-butan-2-yl-N4-[2-(3,4-dimethoxyphenyl)ethyl]-N4-(thiophen-2-ylmethyl)benzene-1,4-disulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-chlorophenyl)sulfonyl-N'-[oxo-[4-(1-piperidinylsulfonyl)phenyl]methyl]-4-piperidinecarbohydrazide | [no description available] | low | 0 | 0 | sulfonamide | |
| N,N-dimethyl-4-[[3-[3-(5-methyl-2-furanyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]sulfonyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-methylphenyl)sulfonyl-3-methylsulfonylimidazolidine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-bromophenyl)sulfonyl-4-[(3-methoxyphenyl)methyl]-1,4-diazepane | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]phenyl]-oxomethyl]imino-3,4-dimethyl-5-thiazolecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-chlorophenyl)sulfonyl-N-(2-thiazolyl)-1-cyclopropanecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-methyl-N-[4-(trifluoromethyl)phenyl]-4-imidazolesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[N-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-methylanilino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N,N-diethyl-4-[[5-oxo-6-(phenylmethyl)-7H-pyrrolo[3,4-b]pyridin-7-yl]amino]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1,3-benzodioxol-5-yl)-5-bromo-1-[cyclopropyl(oxo)methyl]-N-ethyl-2,3-dihydroindole-7-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(3,4-dimethylphenyl)-2-[N-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-methoxyanilino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[N-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-methylanilino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| cyclopentanecarboxylic acid [4-(benzenesulfonyl)-2-tert-butyl-5-methyl-3-pyrazolyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[[(4-acetamidophenyl)sulfonylamino]methyl]-N-(3-methoxypropyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-methyl-N-[2,4,6-trioxo-1-phenyl-5-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-ethyl-2-[[[4-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(2,3-dihydro-1,4-benzodioxin-3-ylmethylamino)-3-nitrobenzenesulfonamide | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| 4-[[(4-methylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(5-chloro-1,3-benzothiazol-2-yl)thio]-N-[3-(4-morpholinylsulfonyl)phenyl]propanamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(6-ethoxy-1,3-benzothiazol-2-yl)-4-methoxy-3-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-ethoxy-3-pyridinecarboxylic acid [2-[2-methyl-5-(4-morpholinylsulfonyl)anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[2-(2-ethyl-1-oxobutyl)-3-phenyl-3,4-dihydropyrazol-5-yl]phenyl]methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[3-[(2-chlorophenyl)sulfamoyl]-4-methoxyphenyl]-4-oxo-4-thiophen-2-ylbutanamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(4-methyl-N-(4-methylphenyl)sulfonylanilino)-N-[(1-methyl-4-piperidinylidene)amino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| fh535 | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-chloro-3-[(2-methoxyphenyl)sulfamoyl]phenyl]-3-(2-methoxyphenyl)urea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-2-(2-pyrimidinylthio)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[[5-(dimethylsulfamoyl)-2-methylanilino]-sulfanylidenemethyl]hydrazo]-2-oxoacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-butylphenyl)-3-[4-chloro-3-(dimethylsulfamoyl)phenyl]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-methyl-2-[[oxo-[4-(1-pyrrolidinylsulfonyl)phenyl]methyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(1,3-benzothiazol-2-ylthio)-N-[2-hydroxy-5-(4-morpholinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-butyl-4,6-dimethyl-3-(2-methylphenyl)sulfonyl-2-pyridinone | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(4-methylphenyl)sulfonyl-3-phenyl-2,3-dihydro-1,4-benzoxazine | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[3-(4-methyl-1-piperazinyl)-1,4-dioxo-2-naphthalenyl]benzenesulfonamide | [no description available] | low | 0 | 0 | 1,4-naphthoquinones;
piperazines;
sulfonamide | |
| N-(2,2,4-trimethyl-3H-benzofuran-7-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-furanyl-[4-(4-propan-2-ylphenyl)sulfonyl-1-piperazinyl]methanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-amino-2-(diethylamino)-N-(2-methoxyphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| N-(1,3-dimethyl-2-oxo-5-benzimidazolyl)-4-fluoro-3-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-(diethylsulfamoyl)-2-methoxyphenyl]-2-[(2,5-dimethylphenyl)thio]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(5-anilino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(1-piperidinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-[3-(1-imidazolyl)propyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[3-(3-oxo-1,2-benzothiazol-2-yl)phenyl]sulfonylamino]benzoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(1,2-dimethyl-5-indolyl)methyl]-4-methoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N,6-dimethyl-2-[[[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]-oxomethyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-cyclopropyl-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[1-(1H-benzimidazol-2-yl)ethyl]-3-(dimethylsulfamoyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(3-methyl-1-piperidinyl)sulfonyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[(1,2-dimethyl-5-indolyl)methylsulfamoyl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,3-dihydro-1,4-benzodioxin-3-carboxylic acid [2-[2-methyl-5-(4-morpholinylsulfonyl)anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-[3-(3,4,5,6-tetrahydro-2H-azepin-7-ylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(1,3-benzothiazol-2-ylthio)-N-[2-chloro-5-(4-morpholinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[3-(dimethylsulfamoyl)phenyl]-3-(2-furanylmethyl)thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-nitro-2-furancarboxylic acid [2-oxo-2-[3-(1-piperidinylsulfonyl)anilino]ethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(4-methoxyphenyl)ethyl]-2-nitro-4-(1-pyrrolidinylsulfonyl)aniline | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| N-(2-ethoxyphenyl)-2,1,3-benzothiadiazole-4-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[3-[2-(4-fluorophenyl)sulfonyl-3-thiophen-2-yl-3,4-dihydropyrazol-5-yl]phenyl]ethanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-[(2-methyl-1-piperidinyl)sulfonyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(3,5-dimethyl-1-piperidinyl)-sulfanylidenemethyl]-2-methyl-5-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[bis(2-methoxyethyl)sulfamoyl]-N-[5-(methoxymethyl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(benzenesulfonamido)-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid propan-2-yl ester | [no description available] | low | 0 | 0 | isopropyl ester;
sulfonamide | |
| 2-(3,4-dichlorophenyl)-N-[3-(dimethylsulfamoyl)-4-methylphenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-Cyclopentyl-2-(N-methyl3-chlorobenzenesulfonamido)acetamide | [no description available] | low | 0 | 0 | sulfonamide | anticoronaviral agent |
| N-[5-(1-azepanylsulfonyl)-2-chlorophenyl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-methoxyphenyl)-3-[3-(1-piperidinylsulfonyl)phenyl]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[2-(trifluoromethyl)phenyl]sulfonyl-4-piperidinecarboxylic acid [2-[(4-fluorophenyl)methylamino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid [2-[4-methyl-3-(1-piperidinylsulfonyl)anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[4-(4-butan-2-ylphenyl)sulfonyl-1-piperazinyl]butanoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-(5-methyl-2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[4-(2-methoxyphenyl)sulfonyl-1-piperazinyl]sulfonyl]benzonitrile | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(diethylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[(4-methyl-1-piperazinyl)sulfonyl]-N-(4-phenyl-2-thiazolyl)-N-prop-2-enylbenzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(7-methyloctyl)-3-[4-(4-morpholinylsulfonyl)phenyl]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-[(5-bromo-2-ethoxyphenyl)sulfonylamino]-2-chloro-N,N-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[5-[(4-fluorophenoxy)methyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-N-(3-sulfamoylphenyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N,N-dimethyl-3-(3-oxo-1,2-benzothiazol-2-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(dimethylsulfamoyl)-N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-methyl-2-[[[4-[methyl(phenyl)sulfamoyl]phenyl]-oxomethyl]amino]-6-propyl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-chloro-3-(4-morpholinylsulfonyl)phenyl]-3-phenylurea | [no description available] | low | 0 | 0 | sulfonamide | |
| dorzolamide | [no description available] | low | 0 | 0 | sulfonamide;
thiophenes | antiglaucoma drug;
antihypertensive agent;
EC 4.2.1.1 (carbonic anhydrase) inhibitor |
| 3-(4-methylphenyl)sulfonyl-3-azabicyclo[2.2.1]hept-5-ene-2-carboxylic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(3,4-difluorophenyl)-2-[N-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-ethoxyanilino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-[(4-methoxyphenyl)sulfonylmethyl]-N-(3-methoxypropyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-cyclohexyl-N-ethyl-1,3-dimethyl-2,4-dioxo-5-pyrimidinesulfonamide | [no description available] | low | 0 | 0 | pyrimidone;
sulfonamide | |
| 1,3-dimethyl-2,4-dioxo-N-(4-propan-2-ylphenyl)-5-pyrimidinesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,5-dimethoxy-N-[[2-(4-methoxyphenyl)-4-thiazolyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| kn 93 | [no description available] | low | 0 | 0 | monochlorobenzenes;
monomethoxybenzene;
primary alcohol;
sulfonamide;
tertiary amino compound | EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor;
geroprotector |
| ro 4-6790 | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| jnj-7706621 | [no description available] | low | 0 | 0 | sulfonamide | |
| sultan | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[2-furanyl(oxo)methyl]-N-[4-[(3-methyl-1-piperidinyl)sulfonyl]phenyl]-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| sb 269970 | [no description available] | low | 0 | 0 | sulfonamide | |
| belinostat | [no description available] | low | 0 | 0 | hydroxamic acid;
olefinic compound;
sulfonamide | antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor |
| 2-bromo-N-(phenylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(2,5-dichlorophenyl)sulfonyl-N-methyl-N-[(2-methylphenyl)methyl]ethanamine | [no description available] | low | 0 | 0 | sulfonamide | |
| ((3z)-n-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1h-pyrrol-2-yl)methylene)-n-methyl-2-oxo-2,3-dihydro-1h-indole-5-sulfonamide) | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-methyl-5-(2-thiazolo[5,4-b]pyridinyl)phenyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-chloro-N-[4-(2-thiazolo[5,4-b]pyridinyl)phenyl]-2-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-methyl-N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | organofluorine compound;
pyrazoles;
sulfonamide | cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug |
| bm 567 | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| mre 269 | [no description available] | low | 0 | 0 | aromatic amine;
ether;
monocarboxylic acid;
pyrazines;
sulfonamide;
tertiary amino compound | drug metabolite;
orphan drug;
platelet aggregation inhibitor;
prostacyclin receptor agonist;
vasodilator agent |
| pazopanib | [no description available] | low | 0 | 0 | aminopyrimidine;
indazoles;
sulfonamide | angiogenesis modulating agent;
antineoplastic agent;
tyrosine kinase inhibitor;
vascular endothelial growth factor receptor antagonist |
| azd2858 | [no description available] | low | 0 | 0 | aromatic amine;
N-methylpiperazine;
pyrazines;
pyridines;
secondary carboxamide;
sulfonamide | antineoplastic agent;
bone density conservation agent;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
Wnt signalling activator |
| 4-(2-((1r)-1-(((4-chlorophenyl)sulfonyl)-2,5-difluoroanilino)ethyl)-5-fluorophenyl)butanoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| apratastat | [no description available] | low | 0 | 0 | sulfonamide | |
| N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| florasulam | [no description available] | low | 0 | 0 | sulfonamide | |
| (1S,2R)-2-[[4-[(2,4-dimethylphenyl)sulfamoyl]anilino]-oxomethyl]-1-cyclohexanecarboxylic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[1-(4-bromophenyl)sulfonyl-3,6-dihydro-2H-pyridin-4-yl]-1,2-dimethylindole | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[3-(3-fluorophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[[4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]phenyl]-oxomethyl]amino]-3-thiophenecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[3-(4-methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-[ethyl(phenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| calcium crimson | [no description available] | low | 0 | 0 | ammonium betaine;
sulfonamide | fluorochrome |
| 4-methoxy-N-[[1-[(3-methyl-2-thiophenyl)-oxomethyl]-3-piperidinyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N'-[[3-(4-methylphenyl)sulfonyl-2-oxazolidinyl]methyl]-N-[2-(4-sulfamoylphenyl)ethyl]oxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| tg101209 | [no description available] | low | 0 | 0 | N-alkylpiperazine;
N-arylpiperazine;
pyrimidines;
secondary amino compound;
sulfonamide | antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor |
| fedratinib | [no description available] | low | 0 | 0 | sulfonamide | |
| WAY-316606 | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes;
piperidines;
secondary amino compound;
sulfonamide;
sulfone | secreted frizzled-related protein 1 inhibitor |
| azd5438 | [no description available] | low | 0 | 0 | sulfonamide | |
| gdc 0941 | [no description available] | low | 0 | 0 | indazoles;
morpholines;
piperazines;
sulfonamide;
thienopyrimidine | EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor |
| 4-methoxy-N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-[methyl-(3-methylphenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| gsk 1016790a | [no description available] | low | 0 | 0 | 1-benzothiophenes;
aromatic primary alcohol;
dichlorobenzene;
N-acylpiperazine;
sulfonamide;
tertiary carboxamide | TRPV4 agonist |
| plx 4720 | [no description available] | low | 0 | 0 | aromatic ketone;
difluorobenzene;
organochlorine compound;
pyrrolopyridine;
sulfonamide | antineoplastic agent;
B-Raf inhibitor |
| gsk 2126458 | [no description available] | low | 0 | 0 | aromatic ether;
difluorobenzene;
pyridazines;
pyridines;
quinolines;
sulfonamide | anticoronaviral agent;
antineoplastic agent;
autophagy inducer;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor;
radiosensitizing agent |
| 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(4-fluorophenyl)sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| (2R)-4-(2,6-difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| [4-(2,6-difluorophenyl)sulfonyl-1-piperazinyl]-(2,3-dihydro-1,4-benzodioxin-6-yl)methanone | [no description available] | low | 0 | 0 | sulfonamide | |
| (2R)-1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| (2S)-4-(2,6-difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| (2S)-1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2-pyridinylsulfonyl)piperazine | [no description available] | low | 0 | 0 | pyridines;
sulfonamide | |
| N-[1-(2,6-difluorophenyl)sulfonyl-4-piperidinyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepane | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[3-(trifluoromethyl)phenyl]sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-azetidinyl]methyl]-2,6-difluorobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[[1-(2,6-difluorophenyl)sulfonyl-3-azetidinyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-pyrrolidinyl]-2,6-difluorobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[3-[(2,6-difluorophenyl)sulfonylamino]propyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-[(2,6-difluorophenyl)sulfonylamino]pentyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[6-[(2,6-difluorophenyl)sulfonylamino]hexyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-[(2,6-difluorophenyl)sulfonylamino]ethyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[1-(2,6-difluorophenyl)sulfonyl-3-pyrrolidinyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[(2,6-difluorophenyl)sulfonylamino]butyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2-nitrophenyl)sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[4-(4-methylphenyl)sulfonyl-1-piperazinyl]-2-thiophen-2-ylquinazoline | [no description available] | low | 0 | 0 | sulfonamide | |
| plx4032 | [no description available] | low | 0 | 0 | aromatic ketone;
difluorobenzene;
monochlorobenzenes;
pyrrolopyridine;
sulfonamide | antineoplastic agent;
B-Raf inhibitor |
| N-[[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(3-chlorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(3-bromophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| (1S,4S)-2-(2,6-difluorophenyl)sulfonyl-5-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2,5-diazabicyclo[2.2.1]heptane | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2,4,6-trifluorophenyl)sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1-cyano-3-pyrrolidinyl)-3-methoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1-cyano-3-pyrrolidinyl)-4-(trifluoromethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1-cyano-4-piperidinyl)-4-(trifluoromethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[3-(3-methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[3-(3-bromophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-cyclohexyl-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2S,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2R,3S)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-cyclohexyl-1-[[(2S,3S)-8-[(4-fluorophenyl)sulfonylamino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-cyclohexyl-1-[[(2R,3R)-10-[(4-fluorophenyl)sulfonylamino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-chloro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[(2S,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2S,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-fluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[(2R,3R)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| baricitinib | [no description available] | low | 0 | 0 | azetidines;
nitrile;
pyrazoles;
pyrrolopyrimidine;
sulfonamide | anti-inflammatory agent;
antirheumatic drug;
antiviral agent;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
immunosuppressive agent |
| 1-(4-methoxyphenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
| 5,6-dimethyl-1-(4-methylphenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
| sr1001 | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| dabrafenib | [no description available] | low | 0 | 0 | 1,3-thiazoles;
aminopyrimidine;
organofluorine compound;
sulfonamide | anticoronaviral agent;
antineoplastic agent;
B-Raf inhibitor |
| 3-[[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepan-1-yl]sulfonyl]aniline | [no description available] | low | 0 | 0 | benzenes;
sulfonamide | |
| 4-[[(4-ethylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| EG00229 | [no description available] | low | 0 | 0 | benzothiadiazole;
dicarboxylic acid monoamide;
L-arginine derivative;
secondary carboxamide;
sulfonamide;
thiophenes | angiogenesis inhibitor;
antineoplastic agent;
neuropilin receptor antagonist |
| gsk0660 | [no description available] | low | 0 | 0 | sulfonamide | |
| xl765 | [no description available] | low | 0 | 0 | aromatic amine;
aromatic ether;
benzamides;
quinoxaline derivative;
sulfonamide | antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor |
| N-(3-chlorophenyl)-3-[[3,5-dimethyl-4-[(4-methyl-1-piperazinyl)-oxomethyl]-1H-pyrrol-2-yl]methylidene]-N-methyl-2-oxo-1H-indole-5-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| tipranavir | [no description available] | low | 0 | 0 | sulfonamide | antiviral drug;
HIV protease inhibitor |
| abt-333 | [no description available] | low | 0 | 0 | aromatic ether;
naphthalenes;
pyrimidone;
sulfonamide | antiviral drug;
nonnucleoside hepatitis C virus polymerase inhibitor |
| pik 75 | [no description available] | low | 0 | 0 | sulfonamide | |
| vx-970 | [no description available] | low | 0 | 0 | sulfonamide | |
| pf-543 | [no description available] | low | 0 | 0 | sulfonamide | |
| ML355 | [no description available] | low | 0 | 0 | benzothiazoles;
monomethoxybenzene;
phenols;
secondary amino compound;
substituted aniline;
sulfonamide | EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
platelet aggregation inhibitor |
| sr9243 | [no description available] | low | 0 | 0 | bromobenzenes;
sulfonamide;
sulfone | antineoplastic agent;
apoptosis inducer;
liver X receptor inverse agonist |
| da 8159 | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[[2-[4-(4-chlorophenyl)sulfonyl-1-piperazinyl]-2-oxoethyl]thio]-6-methyl-2H-1,2,4-triazin-5-one | [no description available] | low | 0 | 0 | sulfonamide | |
| N-tert-butyl-3-(3-tert-butyl-1-methyl-7-oxo-4H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[2-[3-(dimethylsulfamoyl)anilino]-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-[(4-chlorophenyl)methylthio]-4-oxo-1H-pyrimidin-6-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-[(2-chlorophenyl)methylthio]-4-oxo-1H-pyrimidin-6-yl]-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(4-methoxyphenyl)-2-[[6-[(4-methylphenyl)sulfonylamino]-4-oxo-1H-pyrimidin-2-yl]thio]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| mirodenafil | [no description available] | low | 0 | 0 | aromatic ether;
N-alkylpiperazine;
primary alcohol;
pyrrolopyrimidine;
sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent |
| da-8164 | [no description available] | low | 0 | 0 | sulfonamide | |